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CHAPTER I 
ACQUIRED IMMUNE DEFICIENCY SYNDROME 
BACKGROUND 
In 1981 an epidemic of a severe form of acquired immune 
deficiency, now know as acquired immunodeficiency syndrome 
(AIDS), began in homosexual men and intravenous drug abusers 
in New York City, San Francisco and Los Angeles. 8 Since 
that time, states Martha Rogers, M.D., over 7000 cases from 
45 states and 32 foreign countries had been reported to the 
Center for Disease Control. The disease affects primarily 
the cellular immune system and in its severe form results in 
repeated opportunistic infections and malignancies. 
By April 27, 1987, 634 cases of AIDS in children and 
adolescents had been reported to CDC. 7 Children with AIDS 
present a number of difficult problems to educators regard-
ing diagnosis, management and psychosocial problems. 
Therefore the basic purpose of this paper is to review some 
of these issues. 
DEFINITION 
AIDS (Acquired Immune Deficiency Syndrome) is a devas-
tating, fatal disease that destroys some of the immune 
system's key white blood cells, thereby crippling an indivi-
duals' ability to fight off life-threatening infections and 
diseases such as pneumonia, tuberculosis and certain types 
1 
of cancer. It can also attack the nervous system, eventually 
causing permanent neurological damage. The first case of 
AIDS in the United States was reported in 1981. 
The virus that causes AIDS was identified in 1983, and 
is referred to by any of the three acronyms, LAV (Lymphaden-
opathy Associated Virus) , HTLV-III (Human T-Lymphotropic 
Virus Type III) and HIV (Human Immmunodeficiency Virus) or 
simply as the AIDS virus. It is estimated that three to 
eight percent of persons infected with the virus develop 
full-blown AIDS; fifteen to thirty percent develop a related 
but rarely fatal syndrome called ARC (called AIDS Related 
Complex). It is emphasized, however, that anyone infected 
with the AIDS virus is capable of transmitting it to another 
person. 
When an individual becomes infected with the AIDS 
virus, the virus multiplies in certain T-lymphocytes, the 
white blood cells that help fight off infection, and 
destroys them. It may enter other types of cells as well. 
Some individuals become ill within weeks after an AIDS-virus 
infection; others only after five or more years. 
The CDC describes those that slip into a chronic 
debilitating condition called ARC experience symptoms that 
include loss of appetite and weight, fever, "night sweats," 
skin rashes, swollen glands, diarrhea, fatigue and decreased 
resistance to infection. 
2 
The most common initial symptoms of AIDS are a dry 
cough, shortness of breath, weight loss and oral candidiasis 
or thrush (a fungal mouth infection characterized by white 
patches). A disease commonly associated with AIDS is 
Kaposi's sarcoma, in which a cancer or tumor of the blood or 
lurnph system causes purplish skin lesions of the body. 
Sometimes the AIDS virus enters the brain tissue where it 
may cause devastating emotional and behavioral changes. 4 
CASE DEFINITION 
A report by CDC In 1984 gives a case definition for 
AIDS developed before the discovery of the etiology of AIDS 
based on clinical signs and symptoms. 6 A case is defined as 
a child diagnosed as having an opportunistic infection or 
malignancy indicating an underlying cellular immunodeficien-
cy. Other causes of immunodeficiency such as congenital 
immunodeficiencies, congenital infections, medications, 
lymphoreticular malignancy and starvation must be ruled out. 
Because this definition requires the presence of an oppor-
tunistic infection or malignancy, the cases of AIDS retro-
virus infection reported to CDC are the most severe. CDC 
further explains less severe forms of the illness which 
occur. Symptoms associated with AIDS such as generalized 
lymphadenopathy, chronic diarrhea, weight loss or failure to 
thrive, recurrent infections, persistent oral candidiasis, 
interstitial pneumonitis and hepatosplenomegaly have 
3 
occurred in patients belonging to high risk groups. This 
constellation symptoms has been called AIDS-related complex 
and has been used to describe patients in high risk groups 
who have symptoms that are associated with AIDS but who have 
not developed an opportunistic infection of malignancy. 
Since development of the serologic tests for measuring 
antibody to the AIDS virus, antibody to HTLV III/LAV has 
been found in patients with AIDS-related complex and asymp-
tomatic members of high risk groups. 6 HTLV III/LAV has been 
isolated from these asymptomatic seropositive persons 
suggesting that a chronic carrier state can exist. In a 
recently reported study, virus was also isolated from four 
persons who were seronegative. Long-term follow-up of these 
individuals have been planned to clarify the relationship 
between antigen and antibody production and clinical 
symptoms. 20 
DEFINITION ·oF TERMs 26 
Agammaglobulinemia: An immunological deficiency state 
characterized by an extremely low level of generally all 
classes of gamma globulin in the blood, resulting in height-
ened susceptibility to those infectious diseases vulnerable 
to immunoglobulin-associated defense mechanisms. 
Atasia-telangiectasia: Severe progressive cerebellar 
ataxia, associated with oculocutaneous telangiectasia, 
sino-pulmonary disease with frequent respiratory infections 
4 
and abnormal eye movement, a.k.a., Louis Bare Syndrome. 
Concanavalin: Substance which agglutinate the blood of 
mammals. 
DiGeorge Syndrome: Congenital syndrome in which absence of 
the thymus and parathyroids due to defective development of 
the 3rd and 4th ~mbryonic pharyngeal pouches is associated 
with impairment of cell-mediated immunity and normal levels 
of immunoglobulins. 
Hypogammaglobulinemia: a.k.a., agammaglobulinemia. 
Immunoglobulins: Active antibodies, synthesized by lymho-
cytes and plasma cells, responsible for humoral aspects of 
immunity. 
Neutropenia: Decrease in the number of neutophilic leuko-
cytes susceptibility to infection, occasionally anemia and 
thrombocytopenia and hypercellular bone marrow. 
Phytohemagglutinin: A hemagglutinin of plant origin. 
(Hemagglutin: agglutination of erythrocytes). 
Recombinant DNA: DNA that has been artificially introduced 
into a cell so that it alters the genotype and phenotype of 
the cell and is replicated alone with natural DNA. 
Thrqmbocytopenia: Decrease in the number of platelets. 
Therefore, decreases the clotting time since the platelets 
function is chiefly in blood coagulation. 
Wiskott-Aldrich Syndrome: A condition characterized by 
chronic exzema, chronic suppurative otitis media, anemia, 
5 
and thrombocytopenic purpura; transmitted as a sex-linked 
recessive trait called also Aldrich's syndrome. 
ETIOLOGY 
Recent evidence strongly suggests a retrovirus as the 
cause of AIDS. Two prototype viruses were initially identi-
fied independently by investigators at the Institut Pasteur 
in France and at the National Cancer Institute in the United 
States. 10 Evidence indicates that these two viruses are the 
same. 
In 1983 investigators at the Institut Pasteur in Paris 
isolated a retrovirus from a homosexual man with lymphadeno-
pa thy syndrome, a syndrome thought to be a mild form or 
2 percursor to AIDS. This virus, morphologically different 
from the known human retroviruses was termed the lymphademo-
pathy associated virus (LAV) • This virus was subsequently 
isolated from other AIDS Patients, including one patient 
with transfusion-associated AIDS and one of the donors of 
the transfused blood. 9 A seroepidemiologic study showed 
that antibody to this virus was present in more than 70% of 
patients with AIDS or with symptoms strongly suggestive of 
AIDS, in only 1% of healthy blood donors and in none of 
their patients with congenital immunodefiencies. 13 
In 1984, investigators at the National Institutes of 
Health, United States, isolated a retrovirus, termed the 
human T-lymphotrophic retrovirus, type III (HTLV III), from 
6 
a number of patients with AIDS, from patients with symptoms 
strongly suggestive of AIDS and from asymptomatic homosexual 
10 men. The virus was not isolated from healthy heterosexual 
subjects. A seroepidemiologic study found antibody to the 
. . . '1 1 . 21 retrov~rus ~n s~m~ ar popu at~ons. 
Retroviruses are RNA viruses which contain an enzyme, 
reverse transcriptase, that transcribes DNA from RNA, a 
process used in the replication of these viruses. Although 
retroviruses infect many animal species, only two other 
human retroviruses are known: (1) human T cell leukemia/ 
lymphoma virus (HTLV) type I which has been isolated from 
patients with malignancies of the thymus-derived lyumpho-
cytes18 and (2) HTLV type II which has been isolated from a 
patient with aT cell variant of hairy cell leukemia. 19 
The AIDS retrovirus, like other human retroviruses, 
primarily infects the lymphocytes derived from the thymus (T 
lymphocytes) , which are responsible for cellular immunity. 
The AIDS virus preferentially infects the subset of T 
lymphocytes known as helper T lymphocytes which augment the 
immune response. The subset of T lymphocytes which suppres-
ses the immune response, the suppressor T lymphocytes is 
relatively spared and outnumbers the helper T cells. The 
bone marrow-derived lymphocytes (B lymphocytes), which are 




In adults and adolescents over 95% of cases have 
occurred in persons belonging to four high risk groups: 
Group 1, homosexual or bisexual men; Group 2, intravenous 
drug abusers; Group 3, hemophiliacs; and Group 4, the sexual 
partners of infected persons. This epidemiologic evidence 
indicated that, in adults and adolescents, AIDS is transmit-
ted through sexual contact (both heter- and homosexual 
contact) or through parenteral (intravenous) exposures such 
as the sharing of needles used for injectin~ illicit drugs 
or through blood transfusions. 
There are two risk factors in children that are primar-
ily associated with infection: (1) receiving blood or blood 
products; and ( 2) birth to a mother who has AIDS, is a 
member of a high risk group or is a sexual partner of a 
member of a high risk group. 
The route of transmission in those children born to 
high risk parents is unknown, but the retrovirus may be 
acquired in utero, from infective maternal blood at the time 
of birth or postnatally. Data from cases reported to CDC 
suggest that children born to high risk parents may acquire 
infection in utero. The median time interval between birth 
and onset of symptoms in child;ren of high risk parents is 
four months. This is shorter than the median time interval 
8 
of tranfusion-associated illness in which the time between 
transfusion and onset of symptoms is eight months. 
Postnatal transmission, through infected breast milk or 
close contact between the mother and baby, could theoretic-
ally occur. However, none of the 7408 cases reported to the 
CDC as of December 13, 1984, has occurred in individuals who 
were household contacts (nonsexual) of other AIDS patients, 
suggesting that transmission through casual person-to-person 
contact, if it occurs, is rare. All the patients reported 
to CDC with no identifiable risk of exposure deny contact 
with a known AIDS patient. 
mothers has not been cultured. 5 
INCUBATION PERIOD 
Breast milk from infected 
Based upon a report by Dr. David Sencer the incubation 
period (the time between becoming infected and actually 
developing signs of a disease) for AIDS can be quite long. 
In some cases, people have developed AIDS five or more years 
after they were thought to have been infected. Fortunately, 
it appears that only a minority of those infected develop 
symptoms, and only a fraction of these go on to develop 
AIDS. Of those who develop AIDS, most die from their 
disease within two years. Although some have survived for 
as long as five years, it is too early to say if these 
people will become ill again. There is at present, no cure 
for AIDs, although most of the infections associated with 
the disease can be treated. 25 
9 
FIGURE 1. Acquired Immunodeficiency ayndrome uses and known d .. ths. by &-month 
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AIDS must be differentiated from other causes of immune 
deficiency such as treatment with immuno-suppressive drugs, 
congenital immunodeficiencies, congenital infections and 
starvation. A careful history and physical examination 
should rule out immunodeficiency secondary to recent oral or 
parenteral use of steroids or cytotoxic agents and starva-
tion. Malignancies that are associated with immunodefici-
ency, particularly lymphomas, must be considered. Congeni-
tal infections and immunodeficiencies may be more difficult 
to differentiate. 
Cellular immunodeficiency can be associated with some 
congenital infections, such as cytomegalovirus infection or 
rubella. However, this immunodeficiency is temporary and is 
usually less severe than that associated with AIDS. Unlike 
most congenital infections, symptoms associated with AIDS do 
not usually occur in the neonatal period, and developmental 
defects such as cardiac abnormalities have not been reported 
in children with AIDS. Infants with AIDS can acquire 
infections such as cytomegalovirus and toxoplasmosis as a 
result of AIDS, but acquisition is usually not in the 
neonatal period, and these infections are generally much 
more severe than acquired infection in the immunocompetent 
child. 
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Congenital immunodeficiencies to be considered include 
severe combined immunodeficiency, DiGeorge syndrome, Wiskott 
Aldrich syndrome, ataxia-telangiectasia, graft versus host 
disease, neutropenia, neutrophil function abnormality, 
agammaglobulinemia and hypogammaglobulinemia with elevated 
IgM. Unlike patients with severe combined immunodeficiency 
and immunoglobulin deficiencies, patients with AIDS usually 
have markedly elevated immunoglobulins. Unlike children 
with DiGeorge syndrome, children with AIDS have normal 
facies and do not have hypocalcemic tetany. Although 
thrombocytopenia may be seen in children with AIDS, bleeding 
episodes do not usually occur as with Wiskott-Aldrich 
syndrome. Wiskott-Aldrich syndrome, an X-linked recessive 
disease, occurs almost exclusively in boys, whereas about 
40% of children with AIDS are girls. AIDS may be differen-
tiated from neutrophil disorders by its primary effect on 
lymphocytes rather than on granulocytes. 
common feature of AIDs. 24 
TREATMENT 
Ataxia is not a 
Although some therapies have resulted in temporary 
improvement and prolonged survival, to date no effective 
therapy for AIDS exists. Intravenous gammaglobulin is being 
used in some centers with variable success in preventing 
' d f . d ' ' ' 18 B recurrent ep1so es o seps1s an men1ng1t1s. one marrow 
transplantation and lymphocyte transfusion have resulted in 
13 
partial immunologic reconstitution in some cases, but 
. th t 1 . . 1 . 2 4 R b . 1 h 2 w1 ou c 1n1ca 1mprovement. ecom 1nant a p a- -
interferon therapy has been reported to reduce the size of 
the lesions of Kaposi's sarcoma in some cases but did not 
d h . . 1 . h . . 11 s . pro uce c ange 1n 1mmuno og1c c aracter1st1cs. uram1n, 
an inhibitor of reverse transcriptase in vitro, 15 and 
ribavirin, a reported suppressor of replication of LAV in 
1 b . d 16 cu ture, are e1ng assesse • Early diagnosis and treat-
ment of opportunistic infections and malignancies associated 
with AIDS may prolong survival. Careful attention to the 
nutritional and the emotional needs of patients and their 
families is helpfu1. 18 
PROGNOSIS 
The prognosis for HTLV III/LAV infected patients who 
develop opportunistic infections or malignancies is poor. 
Of the 7408 patients reported to the CDC since the epidemic 
began, over 40% have died. Of those patients diagnosed 
prior to 1983, over 80% have died. Of the 103 children age 
18 years or younger with outcome reported to the CDC, 65% 
have died. Although the long-term prognosis of infection 
with HTLV III/LAV has not been determined, a few longitudin-
al studies of high risk patients with symptoms of AIDS but 
without opportunistic infection9 have revealed that as many 
as 20% develop AIDS within three years of onset of symp-
toms14 and up to 50% of adult patients with oral candidiasis 
14 
11 develop AIDS. Similar longitudinal studies in children 
have not been reported. 18 
OCCURRENCE 
Of the 7408 cases of AIDS reported to CDC as of 
December 1984, 107 (1.4%) were in children and adolescents 
18 years of age or younger. The number of cases of AIDS in 
the pediatric population has been steadily increasing since 
diagnosis in 1979 of the earliest case reported to CDC. The 
apparent decrease in cases reported in the latter half of 
1984 probably reflects the lag time between diagnosis and 
receipt of case reports. 
Of the 107 children, 71 (66%) had P.carinii pneumonia, 
5 (5%) had Kaposi's sarcoma, 2 (2%) had both and, 29 (27%) 
had some other opportunistic infection. There were 1.6 
times as many cases in males (66) as in females (41). A 
greater proportion of cases occurred in black (54%) and 
Hispanics (19%) than in whites (27%). The 107 cases were 
reported from 18 states and Puerto Rico with 79% residing in 
New York, New Jersey, Florida or California. 
The majority of pediatric patients with AIDS were 
preschool-aged children. Of the 107 children and adoles-
cents with AIDS, 84 (79%) were younger than six years of age 
at the time of diagnosis of AIDS. All of these children, in 
whom investigations have been completed, acquired AIDS 
either from a blood transfusion (12 children) or because 
15 
they were born to a mother who had AIDS, was a member of a 
high risk group or was a sexual partner of someone in a high 
risk group (60 children) • 7 
PREVENTION 
Since a large proportion of children with AIDS acquire 
the disease through exposure to their parents, prevention of 
AIDS in adults would be expected to prevent cases in child-
ren as well. Behavior modification in adults and adoles-
cents such as reduction of the number of sexual partners, 
especially those in high risk groups, participation in drug 
rehabilitation programs and avoiding the use of nonsterile 
needles may help reduce cases. 
Prevention of congenital cases through birth control 
and abortion are also important: however, the risk of AIDS 
in infants born to infected mothers is unknown. In 11 
mothers who had already delivered one child with AIDS, 12 
subsequent· pregnancies produced four affected infants, 
suggesting that the risk of transmission of the agent is a 
continuing one and that each pregnancy may be at high risk 
for infection. Infected mothers are often asymptomatic 
before and during the pregnancy and at the time of birth, 
making any intervention such as avoidance of pregnancy or 
b . . "bl 23 a ort1on 1mposs1 e. 
16 
CHAPTER II 
SCHOOL MANAGEMENT AND RESPONSIBILITY 
Considerable concern about how children with AIDS 
should be educated has stimulated questions regarding 
exposure of teachers and children to potentially infectious 
body fluids from infected children in the school setting. 
The best answer I think was the message emphasized repeated-
ly at an AIDS conference (National School Board Associa-
tion), that the risk of becoming infected with AIDS virus is 
not greater in school than anywhere else. Schools can plan 
an important role in reducing fear and helping prevent the 
spread of this viral disease by educating students and 
parents about how AIDS is transmitted. 15 
PLACEMENT 
In the event that a school-age child is known to be 
infected with HIV, a team should be developed on an individ-
ual basis to determine advisability of school admission and 
need for any special precautions. Most of my readings 
suggest that this team should include the student's physi-
cian and parents, public health and school personnel. 
Confidentiality should remain an important priority. 
The remote risks of transmission in an educational 
setting are far less than the significant risks of general 
screening and misidentification of children as a result of 
17 
false positive serological tests in a low incidence 
population. Serological testing is recommended only for 
children in high-risk groups {mother with HIV infection, 
hemophilia, sexual contact of individuals with HIV infec-
tion, intravenous drug abuser). 
It is further suggested that a child with HIV infection 
who has uncontrolled behavior primarily as manifested by 
biting, poses a theoretical risk to other children, even 
though transmission by biting has not been documented. 
Any child, including one with HIV, with uncoverable 
open sores should remain out of school until the sores heal 
or can be adequately covered. 
Employees should be instructed in risks of transmission 
of HIV as well as other infectious agents. They should use 
appropriate decontamination measures routinely, including 
dilute hypochlorite solutions to clean environmental surfac-
es and proper handwashing techniques. 
There are theoretical risks of transmission of HIV 
infection by intense contact sports in which bleeding is 
common or by shared use of band instruments. It is stressed 
that no data exist to support such a mode of transmission, 
therefore it is felt to be a remote risk. It would be 
prudent to counsel a known HIV-infected student to abstain 
from such sports or from sharing band instruments. Band 
instructors should be instructed in proper decontamination 
18 
procedures which should be used routinely if band 
instruments are shared. 
Children with HIV-induced immunosuppression are at 
increased risk of severe complications from a number of 
infectious diseases (Chickenpox, Tuberculosis, Measles, 
etc.) and from live vaccines. The risks to the child of 
exposure to other children should be periodically reassessed 
in determining appropriateness of school attendance: they 
should not be required to receive live vaccines as a condi-
tion of school attendance. 
PHYSICAL PROTECTION 
Reported by a panel of AIDS experts at a recent confer-
ence sponsored by the National School Boards Association and 
N.S.B.A. Council of School Attorneys, legal as well as 
medical issues surround the disease AIDS. The decision 
whether to exclude a student with AIDS or AIDS antibodies 
should be determined by the proper medical authorities, said 
Gwendolyn Gregory, deputy general counsel. As long as 
school officials rely on appropriate medical opinions about 
whether a child is infectious in a classroom setting, they 
might avoid legal liability. 3 
Although some states have classified AIDS as a communi-
cable disease, the relevant legal issue concerning AIDS is 
whether it's classified as communicable in the classroom. 
Because no evidence suggests that the virus can be 
19 
transmitted through casual contact, excluding students with 
AIDS on the basis of state communicable disease laws would 
be unwarranted. 
CONFIDENTIALITY 
A physician 1 s unauthorized disclosure of information 
given him by a patient in the course of a professional 
relationship may result in both professional and legal 
sanctions. A hospital has a duty to release a patient 1 s 
privileged information only to the patient, the patient 1 s 
authorized representative, the attending physician, and 
hospital staff members with a legitimate interest. Hospital 
personnel departments should review the hospital 1 s disci-
plinary rules to make sure that they adequately protect the 
privacy rights of AIDS patients. These disciplinary rules 
should be distributed to new employees in a systematic 
fashion and should remind current employees of the current 
rules regarding confidentiality. However, the existence of 
these rules will not provide you with legal protection if 
1 they are not enforced. 
LEGAL ASPECTS 
Okla. Stat. 2503 State the Physician and Psychothera-
pist/Patient Privilege. (4.A) A communication is confiden-
tial if not intended to be disc+osed to third persons, .•. 
Okla. Stat. 503 Suspension or revocation of license 
for unprofessional conduct •.. 
20 
Okla. Stat. 509 Unprofessional conduct. 509-4 
Willfully betraying a professional secret to the detriment 
of the patient ••• 
Okla. Stat. 1-1709 Information concerning condition 
and treatment of patients - Restrictions - Exemptions from 
liability- Review committees ••• 
Assembly Bill No. 403 Existing law provides that the 
results of specified blood tests shall be confidential .•• 
Assembly Bill No. 488 Ref. to Blood banks and plasma 
centers... (Appendix) 
ENVIRONMENTAL PROTECTION 
Elaine Brainerd suggested the following guidelines to 
provide simple and effective precautions against transmis-
sion of disease for all people potentially exposed to the 
blood or body fluids of any student. No distinction is made 
between body fluids from students with a known disease or 
those from students without symptoms or with an undiagnosed 
disease. 
To Avoid Contact with Body Fluids 
Whenever possible, avoid direct contact with body 
fluids. Gloves are recommended. Gloves used for this 
purpose should be put in a plastic bag or lined trash can, 
secured and disposed of daily. 
21 
Direct Skin Contact 
In the instance an un-anticipated skin contact with 
body fluids may occur and gloves are not immediately avail-
able (for example, when wiping a runny nose, applying 
pressure to a bleeding injury outside the classroom) • Hands 
and other affected skin areas of all exposed persons should 
be routinely washed with soap and water. 
Handwashing Procedures 
Proper handwashing requires the use of soap and water 
and vigorous washing under a stream of running water for 
approximately 10 seconds. Soap suspends easily removable 
soil microorganisms, allowing them to be washed off. 
Disinfectants 
An intermediate-level disinfectant should be used to 
clean surfaces contaminated with body fluids. Bleach 
(hypochlorite solution) is preferred for objects that may be 
put in the mouth. A 1:10 solution of sodium hypochlorite 
solution will need to be freshly prepared each day to be 
used for clean-up of body fluids. 
Care of Equipment 
Mops should be soaked in disinfectant after use and 
rinsed thoroughly and washed in a hot water cycle before 
rinsing. Disposable cleaning equipment should be placed in 




AIDS has invaded the human population of the twentieth 
century with a devastating impact that is second to none. 
The recognition and diagnosis of AIDS have aroused the 
concerns of more people about health care and wellness than 
ever before. This elevated level of suspicion by health 
care providers will ensure the diagnosis, reporting and 
monitoring of the incidence of communicable diseases, 
especially AIDS and encourage a consistent surveillance of 
new risk groups for epidemiological concerns. 
A search of literature has defined AIDS as a life-
threatening disease that damages the immune system of 
usually normal, healthy individuals; leaving the body 
defenseless to protect itself from communicable diseases. 
AIDS is non-selective to any socioeconomic group. Any 
person who is exposed to body fluid and/or blood of a person 
infected with AIDS is at risk of becoming infected with AIDS 
also, unless precaution is maintained to prevent it. 
Reported high risk individuals are children who have 
many social problems in addition to the ones associated with 
AIDS. Children with hemophilia may require transfusions 
that could have been contaminated with the AIDS virus. 
Teenagers, men and women may have contacted AIDS through 
23 
homosexual or heterosexual relationships or through the use 
of intravenous drug paraphernalia. 
The possibility of a student transmitting the AIDS 
virus through casual contact in a school setting is remote 
according to research. Available research reports that the 
majority of schools across the nation are without restric-
tion in permitting their students with AIDS to attend 
regular classes. However, if a student is prone to biting 
or other such behavior, incontinence, drooling, etc, a more 
restrictive environment was suggested to minimize the 
exposure of other students to· body fluids at least until 
research can be more definitive. 
It is the duty of the employer to inform the employee 
of diagnosis of a student in his/her charge. It is also an 
obligation to caution the employee of the responsibility to 
maintain confidentiality. 
Health education will be the most significant avenue to 
alleviate the fears of students and the public and to 
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11---------AN ACT RELATING TO EDUCATION; MANDATING AIDS 
PREVENTION EDUCATION FOR STUDENTS; PROVIDING 
PROCEDURES AND REQUIREMENTS FOR SUCH EDUCATION; 
PROVIDING FOR CODIFICATION; PROVIDING AN OPERATIVE 
DATE; AND DECLARING AN EMERGENCY·----------------------------~1 
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: 
SECTION 1. NEW LAW A new section of law to be codified in 
the Oklahoma Statutes as Section 11-103.3 of Title 70, unless there 
is created a duplication in numbering, reads as follows: 
A. Acquired immune deficiency syndrome (AIDS) prevention 
education shall be taught in the public schools of this state. AIDS 
prevention education shall be limited to the discussion of the 
disease AIDS and its spread and prevention. Students shall receive 
such education: 
1. at the option of the local school district, a minimum of once 
during the period from grade five through grade six; 
2. a minimum of once during the period from grade seven through 
grade nine; and 
3. a minimum of once during the period from grade ten through 
grade twelve. 
B. The State Department of Education shall develop curriculum 
and materials for AIDS prevention education in conjunction with the 
State Department of Health. A school district may also develop its 
own AIDS prevention education curriculum and materials. Any 
curriculum and materials developed for use in the public schools 
shall be approved for medical accuracy by the State Department of 
Health. A school district may use any curriculum and materials which 
have been developed and approved pursuant to this subsection. 
c. School districts shall make the curriculum and materials that 
will be used to teach AIDS prevention education available for 
inspection by the parents and guardians of the students that ~ill be 
involvP.d with the curriculum and materials. Furthermore, the 
curriculum must be limited in time fr3me to deal only with factual 
medical information for AIDS pr~venti~n. T~e sc~c~l ~:~~~:r.~~. ~· 
any classroom, shall conduct for the parents and quardians of the 
students involved during weekend and evening hours at least one 
presentation concerning the curriculum and materials that will be 
used for such education. No student shall be required to participate 
in AIDS prevention education if a parent or guardian of the student 
objects in writing to such participation. 
D. AIDS prevention education shall specifical~y teach students 
that: 
l. engaging in homosexual activity, promiscuous sexual activity, 
intravenous drug use or contact with contaminated blood products is 
now known to be primarily responsible for contact with the AIDS 
virus; 
2. avoiding the activities specified in paragraph l of this 
subsection is the only method of preventing the spread of the virus; 
3. sexual intercourse, with or without condoms, wit~ any ?erson 
testing positive for human immunodeficiency virus (HIV) antibodies, 
or any other person infected with HIV, places that individual in a 
high risk category for developing AIDS. 
E. The program of AIDS prevention education shall teach that 
abstinence from sexual activity is the only certain means for the 
prevention of the spread or contraction of the AIDS virus through 
sexual contact. It shall also teach that artificial means of birth 
control are not a certain means of preventinq the spread of the AIDS 
virus and reliance on such methods puts a person at risk for exposure 
to the disease. 
F. The State Department of Health and the State Department of 
Education shall update AIDS education curriculum material as newly 
discovered medical facts make it necessary. 
SECTION 2. This act shall become operative July l, 1987. 
SECTION 3. It being immediately necessary for the preservation 
of the public peace, health and safety, an emergency is hereby 
declared to exist, by reason whereof this act shall take ef!ect and 
be in full force from and after its passage and approval.--------------~ 
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§ 2503. Physician and Psychotherapist-Patient 
Privilege 
A; As used in this section: 
1. A "patient" is a person who consults or is 
examined or intervie\ved by a physician or psycho-
therapist; 
2. A "physician" is a person authorized to prac-
tice medicine in any state or nation, or reasonably 
believed by the patient to be so authorized; 
3. A "psychotherapist" is: 
a. a person authorized to practice medicine in 
any state or nation, or reasonably believed 
by the patient to be so authorized, while 
engaged in the diagnosis or treatment of a 
mental or emotional condition, including al-
cohol or drug addiction, or 
b. a person licensed or certified as a psycholo-
gist under the laws of any state or nation, 
or reasonably believed by the patient to be 
so licensed or certified, while similarly en-
gaged; and 
4. A communication is "confidential" if not in-
tended to be d_isc!osed to third persons, except per-
sons present to further the interest of the patient in 
the consultation, examination or interview, persons 
reasonably necessary for the transmission of the 
communication, or persons who are participating in 
the diagnosis and treatment under the direction of 
the physician or psychotherapist, including members 
of the patient's family. 
B. A patient has a privilege to refuse to disclose 
and to prevent any other person from disclosing 
confidential communications made for the· purpose 
of diagnosis or treatment of his physical, mental or 
emotional condition, including alcohol or drug addic-
tion, among himself, his physician or psychothera-
pist, and persons who are participating in the diag-
nosis or treatment under the direction of the physi-
cian or psychotherapist, including members of the 
patient's family. 
C. The privilege may be claimed by the patient, 
his guardian or conservator or the personal repre-
sentative of a deceased patient. The person who 
was the physician or psychotherapist at the time of 
the communication is presumed to have authority to 
claim_the privilege but only on behalfof the patient. 
D. The following shall be exceptions to a claim of 
privilege: · 
1. There is no privilege under this ·section for 
communications relevant to an issue in proceedings 
to hospitalize the patient for mental illness, if the 
psychotherapist in the c9urse of diagnosis or treat-
ment has determined that the patient is in need of 
hospitalization; 
2. Communications made in the course of a court 
ordered examination of the physical, meptal or emo-
tional condition of a patient, whether a party or a 
witness, are not privileged under this section when 
they relate to the particular purpose for which the 
examination is ordered unless the court orders other-
wise; or 
3. The privilege under this Code as to a commu-
nication relevant to the physical, mental or emotion-
al condition of the patient in any proceeding in 
which the patient relies upon that condition as an 
element of his claim or defense or, after the pa-
tie~t's death, in any proceeding in which any party 
rehes upon the condition as an element of his claim 
or defense, is qualified to the extent that an adverse 
party in said proceeding may obtain relevant infor-
mation regarding said condition by statutory dis-
covery. 
Laws 1978, c. 285, § 503, ef!. Oct. 1, 1978. Laws 1980, c. 
113, § 1, eft. Oct. 1, 1980. 
Witnesses (1::> 208 ct seq. 
Construction and application 
Overton v. Slate, Oki.Cr., 606 P.2d 586 (1979). 
Hospital records 1 
City o! Edmond v. Parr, Okl., 587 P.2d 56 (1978). 
§ 2504. Husband-Wife Privilege 
·A. A communication is confidential for purposes 
of this section if it is made privately by any person 
to his spouse and· is not intended for disclosure to 
any other person. 
'!3·. An accused in a criminal proceeding has a 
pnvilege to prevent his spouse from testifying as to 
any confidential communication between the accused 
and the spouse. 
C. The privilege may be claimed by the accused 
or by the spouse on behalf of the accused. The 
authority of the spouse to do so is presumed. 
D. There is no privilege under this section in a 
proceeding in which one spouse is charged with a 
.,. crime against the person or property of: 
1. The other; 
2. A child of either; 
3. A person residing in the household of either; 
or 
4. A third person when the crime is committed in 
the course of committing a crime against any other 
person named in this section. 
Laws 1978, c. 285, § 504, eff. Oct. 1, 1978. 
Witnesses ~188 et seq. 
§ 503. Suspension or revocation of license for unprofessional 
conduct · 
The State Board of Medical Examiners may suspend or revoke 
the license or certificate of any physician or surgeon holding li-
cense or certificate to practice in the State of Oklahoma for un-
professional conduct, but no such suspension or revocation shall 
be made until such licentiate be cited to appear for hearing. No 
such citation shall be issued except upon sworn; complaint filed 
with the Secretary of said Board, charging the said licentiate 
with having been guilty of unprofessional conduct and setting 
forth the particular act or acts alleged to constitute such unpro-
fessional conduct. In the event it comes to the attention of said 
Board that a violation of the rules of professional conduct may 
have occurred, even though a formal complaint or charge may 
not have been filed, said Board may conduct an investigation of 
such possible violation, and may upon its own motion institute a 
formal complaint. In the course of such investigation persons 
appearing before the Board may be required to testify under 
oath. Upon the filing of such complaint, either by an individual 
or the Board as provided herein, such citation must forthwith be 
issued by the Secretary of the Board over his signature and seal 
of the Board, setting forth the complaint of said unprofessional 
conduct, and giving due notice of the time and place of the hear-
ing thereof by the Board of Medical Examiners. The said cita-
tion shall be made returnable at the next regular meeting of the 
Board occurring at least thirty .(30) days next after the service 
of said citation. The acccscd shall file his written answer there-
to under oath with the Secretary of said Board within twenty 
(20) days after the service upon him of said citation and there-
with shall deposit with the Secretary his license or certificate au-
thorizing him to practice medicine and surgery within this State 
and unless such answer with such license or certificate be filed as 
herein set forth, the accused shall be considered in default and 
his license or certificate suspended or revoked, if the charges be 
deemed sufficient by the Board ; provided, that the Secretary of 
the Board may extend the time of answer upon satisfactory show-
ing that the defendant is for rE'.asonable cause, unable to make 
answer within the said twenty (20) days, but in no case shall the 
time be extended beyond the date of the next regular meeting of 
the Board, unless continuance thereof be granted by the Board. 
Laws 1923, ch. 59, p. 108, § 23. Amended by Laws 1955, p. 328, 
§ 1. 
§ 509. Unprofessional conduct-Definition 
The words "unprofessional conduct" as used in this Act are 
hereby declared to mean : 
First. Procuring, aiding or abetting a criminal operation or 
abortion. 
Second. Advertising in any manner, either in his own name 
or under the name of another person, firm, association or corpo-
ration, in any newspaper, pamphlet, circular, or other written or 
printed paper or document, the.treatment of or the curing of ve-
nereal diseases, or the private diseases peculiar to men and wom-
en, or the advertising, or holding himself out to the public, in 
any manner as a specialist in the diseases of the sexual organs, 
or diseases caused by sexual weakness, self-abuse or excessive in-
dulgence, or in any disease of like nature produced by like caus-
es, or the restoration of "lost manhood," or the advertising of 
any medicine, or any means whatsoever, whereby the monthly 
periods of women can be restored or regulated or the menses be 
re-established, if suppressed, or being employed by, or in the 
service of, any person, firm, association or corporation so adver-
tising. 
Third. The obtaining of any fee or offering to accept any fee, 
present, or other form of remuneration whatsoever, on the assur-
ance or promise that a manifestly incurable disease can or will 
be cured. 
Fourth. Wilfully betraying a professional secret to the detri-
ment of the patient. 
Fifth. Habitual intemperance or the habitual use of habit-
forming drugs. 
Sixth. Conviction of a felony or of any offense involving 
moral turpitude. 
Seventh. The employment of what is commonly known as 
4 'Cappers" or "Steerers" in procuring practice. 
Eighth. All advertising of medical business in which state-
ments are made which are grossly untrue or improbable and cal-
.culated to mislead the public. 
Ninth. Conviction or confession of a crime involving the vio-
lation of the anti-narcotic or prohibition laws and regulations of 
the Federal Government, or the Board of Health laws and regu-
lations of the State of Oklahoma. 
Tenth. Dishonorable or immoral conduct. 
Laws 1923, ch. 59, p. 110, § 29. Amended by Laws 1925, ch. 63, 
p. 96, § 5. 
§ 1-1709. Information concerning condition and treatment of 
patients-Restrictions-Exemption from liability-Re-
view committees 
Any authorized person, hospital, sanatorium, nursing home or 
rest home, or other organization may provide information, inter-
views, reports, statements, memoranda or other data relating to the 
condition and treatment of any person to any of the following for 
use in the course of studies for the purpose of reducing morbidity 
or mortality: The State Board of Health; the Oklahoma State 
Medical Association, or any committee or allied society thereof; the 
American Medical Association, or other national organization ap-
proved by the State Board of Health, or any committee or allied 
medical society thereof; or any in-hospital staff committee. No 
liability for damages or other relief shall arise Qr be enforced 
against any authorized person, institution or organization by reason 
of having provided such information or material, or by reason of 
having released or published the findings and conclusions of such 
groups to advance medical research and medical education, or by 
reason of having released or published generally a summary of 
such studies. The recipients shall use or publish such information 
or material only for the purpose of advancing medical research or 
medical education in the interest of reducing morbidity or mortality, 
except that a summary of such studies may be released by any such 
group for general publication. In all events, the identity of any 
person whose condition or treatment has been studied shall be 
confidential and shall not be revealed under any circumstances. 
Any information furnished shall not contain the name of the person 
upon whom information is furnished and shall not violate the 
confidential relationship of patient and doctor. All information, 
interviews, reports, statements, memoranda, or other data fur-
nished by reason of this section, and any findings or conclusions 
resulting from such studies, are declared to be privileged communi-
cations which may not be used or offered or received in evidence in 
any legal proceeding of any kind or character, and any attempt to 
use or offer any such information, interviews, reports, statements, 
memoranda or other data, findings or conclusions, or any part 
thereof,· unless waived by the interested parties, shall constitute 
prejudicial error in any such proceeding. Physicians and others 
appointed to hospital utilization review committees for the purpose 
of determining the optimum use of hospital services shall be im-
mune from liability with respect to decisions made as to such 
utilization and actions thereunder so long as such physicians or 
others act in good faith; provided, however, that nothing in this 
section shall be construed to relieve any patient's personal physician 
of any liability which he may have in connection with the treatment 
of such patient. 
Laws 1963, c. 13, § 1. Laws 1968, c. 215, § 1, eff. April 23, 1968. 
. ·: .. 
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AIDS-MANDATORY BLOOD TESTIN~ONFIDENTIAI.JTI: 
Assembly Bill No. 403 _ .. 
CHAPTER 22 . . . ·· .. 
·An act to add Chaptel" 1.11 (eonunencing with Section 199.20} to 
Pa:tt 1 of Division 1 of the Health and Safety Code. reLlting to health, 
and declaring the urgency thereof, to take effeet immediately. 
· [Approved by Governor A;rU 3, 19133. rtled ~th · 
Secretary of State April 4, 19133.) 
. . .. ·. : 
. LECISL.A TlVE COUNSEL'S DIC~ . : 
AB 403, Agnos. Health. 
(1) Eristing law provides that the results of specified blood tesu 
shall be confidential and not open to public inspection. · 
This bill. in addition to existing law, would provide that no person 
~~be compelled, as specified. to identify any individual who is the 
subject of a blood test .to. detect antibodie$ to the probable causative 
agent of acquired immune deficiency syndrome. The bUl would 
provide penalties for disclosure, a.s defin~ of the re.rult:s of the blood 
test, u defined, except as specified, including the assessing of civil 
penal tie$ and the creation of a new misdemeanor. It would establish 
a right of action for actual damages. Creation of a new misdemeanor 
constitutes a stat~mandated local program: • . · 
•rm'* V lnclkates text delerioft 




Ch. 22 STATUTES OF 1985 . . 
This bill would permit the State Department of Health Service3 to 
require blood banb and. pl.asm.a centers t(? submit reports 
summ.a.rlz:ing data concerning tests to detect the pre:~ence of viral 
hepatitis and antibodies to the probable causative agen_t of .AlD~. as rpecified. . . . . . -~ . . 
It would prohibit: a· person. ex~ept ·as specified."-'fi..om. t·ks~g a 
penon's blood for cvidenpc of. antibodies to t?e "proba?lo causatiy~ 
agent of AIDS without tlle wptten consent Of the subJect. . · , ... 
This bill would prescribe that the results of the blood test not ~ 
wed in any iiuUnce for th~ determ.4lation of insurabilitY.. or 
suitability for employmenL . ' , · · . : · · . . : · 
It would also prescribe that neither the state department nor any 
blood ba.nlc or plasma center, including a blood bank or pla..sma 
center operated by a public entity. be. liable for _any damages 
resulting·from a specified notification of test results: · - .. : 
(2) The California. Constitution requires the state to reimburse 
local agencies and school districts for certain costs mandated by the 
state. Statutory provisioru establ.i..sh procedures for maldng that 
reimbUrsement, including the creation of a State Mandates Cla.im.s 
Fund to pay the costs of mandates wruch do not exceed $500,000 
statewide and other procedw:es for claims whose statewide costs 
exceed $.500,000. . 
1b.i.s bill would provide that no reimburseme.nt shall be made from 
the State Mandates Claims Fund for costs mandated by the state 
pursuant to this· act, but w-Ould: recognize that local agencies and 
school districts may. pursue any available remedies to seelc 
reimbursement for some of these com. · · · 
This bill would provide that, notwithstanding Section 223US of the 
Revenue and Taxation Code, this bill does not contain a repealer, as 
requ.ired by that section; therefore, the- provisioru of the bill would 
remain in effect unless and until they are amended or repealed by 
a later enacted bill. . . · · · . • · · . . · · · ' . 
The bill would take effect imm~ately as &;n urgency statute:· · 
. . ~ · ... 
The people of the State of Csl.ifornh do emct as folloW$:" 
. . .· .. ·. . .-... . . 
SECTION 1. Chapter 1.11 (commencing with Section 199.20) is 
added to Part 1 of DivUion 1 of the Health and Safety Code, to read: 
~. .. .. :. · .. · 
CHA..PTER 1.11-· MANDATED BLOOD TE:snNc. ~· ·. 
CONFIDENTIALITT TO PROTECT PuBuc -HE.u.TB ·-: · .. ; . ~ . . .. ~· . . . ; . .· . 
199.20. To protect the privacy of individuals whO ar.e the subject 
of blood testing for: antibodies to the probable eawative agent of 
acquired immune deficiency syndrocie (AIDS) "the following ahall 
apply; .. ... .. . . : '· .• 
Exdept as provided in Secfu~ 1003.1 or 1003.3, as amended by. AS 
488 of the 19&5-86 Regular Session, no penon shall be compelled tn 
any state, county, city, or other local dvil. criminal, adminirtratfve. 
legislative, or other proceedings to identify or' provide identifying 
24 
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characteristics ·which would identify any individual who IS the 
subject of a blood t~t to detect antibodies to the probable causative 
agent of AIDS. • . · : . . . . . . 
199.21. (a) Any person who negligen~ clliclose3 resti.lti of• a 
blood test to detect antibodie;, to the prpbible causative agent of 
acquired immune deficiency syndrome to any third ·party, except 
pursuant to a written authorization, B.! described in subdivmon (g), 
or except as provided in Section 1603.1 Ot' 1603.3, 83 amended b,.. AB · 
488 of the 198$-86 f{egular Session, shall be asressed a civil penalty 
in an amount not to exceed one thousand dollan {U,OOO) plus court 
cos~. as determined by the court, which penalty and costs shall be 
paid to the subject of the test.- . · • · · · · ' ··-' · · ·. · · · 
(b) Any person who willfully d.i.sclose3 the resul~ of a blood test 
to detect antibodies to the probable causative ~~:gent of the _acquired 
immune deficiency syndrome, to any third party, except·pursuant to 
a written authorization, 8-' described in subdivision (g), or except .u 
provided in Section 1603.1 or 1603.3, as amended by AB 488 of the 
1985-88 Regular Session, shall be assessed a civil penalty in an amount 
not leS3 than one thousand dollars ($1,000) and not more thari. five 
thousand doll_ars ($5,000) plus court costs, 8-' determined by the 
court, which penalty and costs shall be paid to the subject of the tert. 
(c) Any person who willfully or negligently discloses the results of 
a blood test to detect antibodies to the probable causative agent of 
acquired immune deficiency· syndrome to a third party, except 
pu.rru.ant to a written authorization, as described in su,bdivision (g). 
or except as provided in Section 1603.1 or 1603.3, as amended by AB 
488 of the 1985-86 Regular Sessio'n, which results in economic, bodily, 
or psychological harm to the subject of the te;,t, is guilty of a 
misdemeanor, punishable by imprl.sonment in the county jail for a 
period not to exceed one year or a fine of not to exceed ten thousand 
dollars ($10,000) or both. ·. 
(d) Any person who commib any act described in subdivision (a) 
or (b) shall be liable to the subject for all actual damages, including 
da.m.ages for economic, bodily, or psychological harm· which . is a 
proximate cause of the act · · . . · ' 
(e) Each disclosure made in violation of thi$ chapter is a separate 
and actionable offense. · · · 
(f) The results of a blood test to detect antibodies to the probable 
causative agent of acquired Immune deficiency syndrome shall not 
be used in any instance for the detenninatioa of insurability or 
'suitability for employment. · · · 
(g) 'Written authorization,'' as used in thil section, applies only 
to the clliclorure of test results by a person responsible for the care 
and treatment of the person subject· to the test. Written 
authorization Is required for each separate clliclosure of the test 
results, and shall include to whom the disclosure would be made. 
(h) Nothing in thiS section Umits or expands the right of an injured 
subject to recover damages under any'other applicable law. 
(i) Nothing in this section shall be construed to impose liability or 
criminal Ja.Ilction for clliclorure of a blood test to detect antibodies 
tymbol V lndiccrtn text cfel.tion - ..... _ .. ·:. 
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to the proba.bl. causative agent of. AIDS in accordance.. with anr 
reporting requirement for a diagnOsed case of AIDS by the state 
department or the Centers for DUeasc Control under .the United 
States Public Health Services.. . . . : r • -
(j) The mt:e department may. reqwre blood ba..nlci and "plasma 
centon to rubmit monthly report:J surnm.arlzing statistical data 
ccmceming the resulb of ~b to detect the presence of viral hepatitis 
and antibodies to the probable causative agent of AIDS. This 
statisticaliUIIlillU)' shall not include the identity of individual donors 
or ident::i.fyiJll characteristics which would _identify individual donors. 
.(k) .. Disclosed,'' u wed in this teCtion, means to discla.e, relea.se, 
·transfer, diiseminat.e, or otherwise comm,mlcato all or ~y.part Of 
any record orally, in wrl~ ~ by electronic mt-.anJ to ~):' person 
or entity. : • . . . . · . . . . · 
(1) .. ResultJ. of a bloOd t:Cst.H u wed in this section, means to 
identify or provide identifying cJ:w'acteJ:Utics of the person .to whom 
the resulb apply. . · · . . . . 
199.22. No person shall test a pemn's blood for evidence of' 
antibodies to the probable causative agent of AIDS ~thout the 
written consent of the subject of the test. and the person giving the 
test ~all have a written statement signed by the subject confirming 
that he or she obtained the consent from the subject. . 
nus requirement does not apply to a test performed at an 
alternative site, as established pursuant to. Article 8 (cOmmencing 
with Section 1630) of Chapter .f of Division 2. nus requirement also 
does not apply to any blood. and blood products specified in 
paragraph (2) of subdivision (a) of Section 1603.1. as amended by 
Assembly Bill 488 of the 1985-86. Regular Session. : .. . : . 
199.2.3. Neither. the state department nor any blood banlc or 
plasma center, including a blood bank or plasma center. owned or 
operated by a public entity, shall be held liable for ar!y damages 
resulting from the notification of test results, a.s set forth in paragraph 
(3) of subdivision (a) of, and in subdivision (c) of, Section 1603.3, a.s 
amended by AB 488 of the 198.5-86 Regular Session. ... · . . 
SEC. 2. (a) No reimbursement is required by thU act pursuant 
to Section 6 of Article XIII B of the California Constitution because 
part of the costs which may be incurred by a local agency or school 
district will be incurred because this act creates a new crime or 
infraction. changes the definition of a crime or infraction. chariges 
the penalty for a crime or. infraction. or eliminates .a ~e or 
i.Ilfraction. · · · ." . - ' 
(b) No reimbursement shall be made from the State Mandates 
Claims Fund pursuant to Part 7 (commencing with Section 17rol) 
of Division -4 of Title 2 of the GOvernment Code for co.sts mandated 
by the state pursuant to this act. It is recognized, however, that a local 
agency or school district may pursue any r~medies to obtain 
reimbursement available to· it under Part 7 (commencing with 
Section 17500) and any other provisions of law. 
SEC. 3. Notwithstanding Section 2231.!5 o£ the Revenue and 
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that section; therefOre, the pravisioru ofthU act shall rem&m in effect 
unless and until they are amended or repealed by a later enacted aq. 
SEC. 4. This act u an urgency statute necessary for the 
immediate preservation of the pubUc peace, heal~ or safety within 
the meaning of Article IV of the Cor..stitution ·and shall· go into 
immediate effect. The facts constituting the necessity are: . ·. 
In order to protect the confidentiality. of persons undergoing a 
blood test for the detection of anitbodie3 to . acquired immune 
deficiency syniJrome, and to encourage individuals who are stricken 
with the disease to undergo treatment" which would ultimately 
benefit the health and welfare of all citizens o(the State of California, 
it is necessary that this act take immediate effect · · · . .:. ~ . 
. . ':: 
AIDS-BLOOD BANKS AND PLASMA:· CENTERS-
. ANTIBODYTESTING· . 
Assembly Bill No. -488: · 
CHAPTER 23 
An act to amend Sections 199.21 and 1603.1 of, to add Sections 
1603.3 and 1003.4 to, and to add Article 8 (commencing with Section 
1630) to 'Olapter 4. of Division 2 of. the Health and Safety Code, 
rclatiilg"to Iieilth. m..alcmg an appropriation therefor. and declaring 
.the urgency thereOf,. to talce effect immediately .... 
lApproved by Covernor April3, 196.5.'Filed with. 
ScCTetary of StAte Aprilt, 196:5.} · · . 
. · : LECISLATIVE COUNSEL'S. DIGEST ....... . 
AB 488, Roos. Blood banh and plasma centen: AIDS. 
(1) Existing law requires each blood bank, ~defined, to make 
tem of all human whole blood received to detect the presence of 
viral hepatitis. . . 
This bill would require each blood banlc and plasma center, as 
defined. to test for the probable cawative agent for acquired 
inimune deficiency syndrome, except as specified. It would prohibit 
bloOd or blood components to be used in vivo for human.!, unless the 
blood or blood componenb have been so tested ·and labeled 
nonreactive, except a.s specified. It would require all blood donors to 
be given upecified'written notice and to sign a written confirmation 
of ilii3 notification. It would require blood 'ba.nb and plasma centers 
to utilize self-deferral and callback procedure:~. It would require 
blood han1c:! and pla.sma centers, lifter a confirmation test, to report 
information to the State Department of Health Services· to be 
Included iri a Donor Deferral Register, u specified. It would require 
laboratorie:s which make the antibody test to be specially approved 
•ymbol 'il lndkat" tut del.tloft ' · · 
ACQUIRED IHHUNODEFICIENCY SYNDROME 
HONTHLY SURVEILLANCE REPORT 
CUMULATIVE TOTALS 
April 27, 1987 
UNITED STATES CASES REPORTED TO CDC 
Known Reported 
PRIMARY DISEASE REPORTED Cases Deaths % Dead Since 1-1-87 
Pneumoc~stis carinii Pneumonia 22692 13246 58% 3979 
Other Opportunistic Infections 7858 4910 62% 1450 
Kaposi's Sarcoma 4518 2085 46% 609 
Total 35068 20241 58% 6038 
AGE RACE 
.. 
Under 5 435 1% White 21118 60% 
5-12 58 0% Black 8662 2 5% 
13-19 141 0% Hispanic 4950 14% 
20-29 7357 21% Other & Unknown 338 1% 
30-39 16388 47% 
40-49 7259 21% Total 35068 100% 
Over 49 3430 10% 
SEX 
Total 35068 100% 
Male 32459 93% 
Female 2609 7% 
Total 35068 100% 
TRANSMISSION CATEGORIES Cumulative Since 1-1-87 
Homosexual or Bisexual Men 22705 65% 3972 66% 
r.v. Drug User 5793 17% 880 15% 
Homosexual Male and IV Drug User 2634 8% 390 6% 
Blood Transfusion 745 2% 171 3% 
Hemophilia/Coagulation Disorder 330 1% 61 1% 
Parent w/AIDS or increased risk 389 1% 66 1% 
Heterosexual Contact 1335 4% 216 4% 
None of the above/Other 1137 3% 282 5% 
Total 35068 100% 6038 100% 
ACQUIRED IMMUNODEFICIENCY SYNDR01{1: 
MONTHLY SURVEli.LANCr~ REPORT - OKLAHOMA 
CUMULATIVE TOTALS 
April 30, 1987 
OKLAHOMA CASES REPORTED 
Known Reported 
Cases Deaths 7. Dead Since 1-1-87 
Pneumocystis carini.i Pneumonia 70 45 64% 17 
Other Infections 32. 17 53% 3 
Kaposi's Sarcoma 13 5 387. 3 
115 67 58% 23 
AGE RACE 
Under 5 1 1% t-lh i. te 100 877. 
5-12 Black 11 10% 
13-19 Indian 2 2% 
20-29 34 30% Hispanic 2 2% 
30-39 51 44% Other -- i. 
40-49 14 12% Total 115 100% 
Over 49 15 13% --
Total 115 100% 
SEX 
Male 109 9 5% 
(Mean age 35 years) Female 6 5i. 
Total 115 100% 
TRANSMISSION CATEGORIES Cumulative Since 1-1-87 
Homosexual or Bisexual Male 
I.V. Drug User . 
84 73% 18 I 78% 
5 4% '--
Homosexual Male and I.V. Drug User 
Blood Transfusion 
12 10% 31, I, 13% 
Parent w/HIV Infection 
Heterosexual Contact 











2% 1 4% 
5% . 1 4% -
100% 23 100% 
Addendum: 
I. Policy: Communicable Diseases 
Admission and Management of Students with AIDS 
Students with AIDS 
II. Curriculum Guide for Teachers 
42 
I Tulsa Public Schools I BPS Code: JBCC 
Communicable Diseases 
Any student afflicted with a communicable or contagious disease will 
be prohibited from attending school in this district until he/she is 
free from such a disease, or until a plan for management of the case 
has been determined which will adequately protect others in the 
school environment against transmission of the disease. 
Adopted: 
Legal Reference: Title 70, o.s. 1210.194 
I Tulsa Public Schools I EPS Coile: JBCC-R 
Admission and Management of Students with 
Acquired Immune Deficiency Syndrome (AIDS) 
Acquired Immune Deficiency Syndrome (AIDS) is one of a number of 
communicable diseases which require special precautions to prevent 
their transmission in the school environme~t. However, because 
there is no cure for AIDS and because it is a life-threatening dis-
ease, it is imperative that very specific procedures be followed in 
the management of any case of a student with AIDS. 
Nature of the ~IDS Virus 
AIDS is a disease which disables the body from fighting infection. 
The cause of the disease is infection by the Human T-Lymphotropic 
Virus, Type III (HTLV-III), also known as Human Immunodeficiency 
Virus (HIV). Three categories of outcomes result from infection by 
HTLV-III. The first, AIDS, is the most severe form of the infection 
and most victims die within two years. The second form of infection 
is AIDS-Related Complex (ARC), a milder form with less severe symp-
toms. The third and most common form of infection by HTLV-III 
causes the affected person to be an Asymptomatic Carrier, having no 
symptoms but still believed capable of transmitting the virus to 
others. Based upon the medical evidence available, it must be 
assumed that each of the three levels or stages of HTLV-III infec-
tion is contagious under certain conditions. 
Transmission of AIDS 
Fortunately, AIDS, unlike many other communicable diseases, is not 
believed by most medical authorities to be transmissible through the 
casual contact which would typify the normal school environment. 
AIDS is acquired by the introduction of the virus into the blood 
stream through sexual contact, sharing of hypodermic needles among 
intravenous drug users, receiving blood transfusions from infected 
individuals, or at birth. ·Pending further research, however, any 
spill of body fluid--blood, tears, semen, saliva, vomitus, urine or 
excrement--by an AIDS infected individual should be considered as a 
possible source of infection. 
Cleanup of Body Fluids 
Since it is not always known which children may be infected with the 
HTLV-III virus, rubber gloves and a 1 to 10 solution of household 
bleach in water are to be used in cleaning up a spill of body fluid 
by ~ student. Insofar as possible, paper towels or other dispos-
able products are to be used. Following cleanup, the rubber gloves 
and paper towels are to be sealed in a plastic bag and discarded. 
Other materials used in the cleanup, such as mop heads, rags, or 
clothing, are to be thoroughly rinsed in a bleach and water solution 
or washed separately in hot water. Band instruments which are 
shared among students are to be thoroughly decontaminated between 
uses. Thorough hand washing with soap and water is also advised. 
These precautions will help to guard against the spread of not only 
AIDS but other more communicable, though less deadly, diseases. 
Referral to Health Evaluation Team 
Any student found to be infected with the HTLV-III virus, even if no 
symptoms are evident, should be reported immediately in writing to 
the Superintendent of Schools. The Superintendent will appoint a 
Health Evaluation Team consistin~ of the following individuals: 
- Director of Elementary, Middle or High Schopl 
Education (Chairperson) 
- Principal of the student's school 
- Director of Health Services 
- Representative of Tulsa City County Health Department 
- Student's physician 
- Student's parent(s) or guardian(s) 
The Health Evaluation Team will consider all available data regard-
ing the student and will recommend to the Superintendent the most 
appropriate educational environment· for that student, as well as any 
special conditions or precautions. The Team will review the case at 
least annually, or more often as needed. 
Right of Appeal 
A parent who disagrees with the assignment and/or conditions of 
attendance prescribed for an HTLV-III student may send a written 
request to the Superintendent of Schools describing the reasons for 
the appeal. The Superintendent will refer the case to a Health 
Review Board for hearing and disposition. The members of this Board 
shall include the following: 
- Consulting Physician to the Tulsa Public Schools 
- Representative of the Division of Instruction 
- Representative of the Division of Instructional Support 
Services 
- Representative of the Division of Business and Personnel 
Services 
The Health Review Board will send a written report of their conclu-
sions and recommendations to the Superintendent of Schools who will 
respond to the parent(s). 
Protection of Other Students 
The first consideration must be the protection of other students 
from infection by the AIDS student. Since the possibility of 
spreadinq the HTLV-III virus through casual contact such as occurs 
in a school situation is "remote," according to medical researchers, 
most AIDS students can continue without restriction in the regular 
classroom, except that such students are not to be allowed to par-
ticipate in contact sports. But if a child is prone to biting or 
other similarly aqgressive behavior, is incontinent, has open skin 
lesions, or is subject to drooling, a more restrictive environment 
which minimizes the exposure of other children to his/her body 
fluids will be prescribed by the Health Evaluation Team. Any em-
ployee assigned to work with this type of child must be informed of 
the potential contagiousness of the student. 
Protection of AIDS Students 
A second consideration is the physical well-being of the AIDS af-
flicted child. Since AIDS severely depresses the immune system, any 
of the minor infections or childhood diseases which are common among 
children could be life threatening to a child afflicted with AIDS. 
It may thus be advisable to recommend a restricted educational envi-
ronment, either permanently or temporarily, for the protection of 
the AIDS student. 
Confidentiality·Requirements 
Protection of the confidentiality of information reqardinq HTLV-III 
infected students is of utmost importance. Only those employees who 
have an absolute need to know are to be maC!e aware of the identity 
of AIDS students. The Health Evaluation Team will identify by name 
those employees who are to be given this information. This list 
will be given to the principal who will he responsible for ensuring 
that only authorized employees are made aware of the student's con-
dition, and that they are informed of the potential legal liabili-
ties of revealing that information. When an HTLV-III student is 
identified, the principal is to establish a separate file on that 
student to which only he and those identified employees are to have 
access. No entry regardinq.the AIDS condition is to be made on the 
student's cumulative record, health card, the computerized student 
data base or other record. 
Issued: Waiting on legal opinion 




Oklahoma State Department of Education 
john M. Folks. Ed.D. 
State Superintendent of Public Instruction 
Oklahoma State Department of Health 
joan [. Leavitt. M.D. 
Commissioner of Health 
ACQUIRED IMMUNE DEFICIENCY SYNDROME {AIDS) PREVENTION EDUCATION 
GENERAl. OBJECTIVE: Be aware of the forms of the disease. the methods of 
transmission, and prevention of Acquired Immune Deficiency Syndrome 
(AIDS). 
EXPECTED OUTCOMES: 
l. Understand . origin and history of Acquired Immune 
Deficiency Syndrome. 
2. Define AIDS. 
3. Namo tho causo of AIDS. 
-1. List the methods of transmission of AIDS. 
5. List the methods of prevention. 
6. List and describe the forms of the lliV infections. 
7. Identify tests for the HIV infections. 
8. Describe methods of care and treatment. 
9. List the groups at high risk for acquiring the lliV infection. 
10. Understand that a woman who is infected with the IIIV and 
becomes pregnant, is more likely to develop ARC or classic 
AIDS. 
11. ldontify misconceptions about AIDS. 
12. Identify authoritative sources of information about AIDS. 
In order for our staff to assist local schools in the preparation 
for the implementation of Acquired Immune Deficiency Syndrome 
(AIDS) Prevention Education, the State Board of Education hereby 
declares that an emergency exists with imminent peril to the public 






(Sexual abstinence) Refraining from all types of sexual 
intercourse (oral. anal. and vaginal). 
Resulting from events which occur after birth: not 
inherited. 
To feel unable to do without something. such as drugs or 
cigarettes: to be "hooked" on something. 
Acquired Immune Deficiency Syndrome. A fatal illness 
caused by a virus that damages the body's immune system. 
AIDS-Related Complex A condition in which a person infected with human 
(ARC) - immunodeficiency virus (HlV) has a set of specific 











Insertion of the penis into the rectum. 
Substance which kills or prevents multiplication of 
bacteria. 
Substances in the blood made by the immune system to 
fight against germs. 
Substance which prevents multiplication of viruses. 
The rear opening of the digestive tract. Bulk waste (feces. 
stool) passes out of the body through this opening. 
See "AIDS-Related Complex" 
Not natural. Artifical methods of birth control include 
chemical and mechanical methods. 
Azidothymidine. A drug which may help to prevent 
oppo.::tunistic infections in some patients with AIDS. 
A substance or material used to prevent pregnancy, such 
as condoms, spermicides, and oral contraceptives ("the 
pill"). 




















Nonsexual body contact including touching, hugging, 
handshaking, and sitting closely together. 
Medications used to treat certain viruses, bacteria. or 
cancer cells. 
A sexually transmitted disease caused by bacteria that can 
infect males and females, often without causing 
symptoms. If left untreated, may cause sterility. 
Disease that can be passed from person to person caused 
by bacteria, viruses, and other organisms. 
A rubber cover or sheath worn over the penis. Used 
during sexual activity to prevent AIDS. other sexually 
transmitted diseases, and pregnancy . 
• 
Come in contact with or made impure by exposure to 
material or organisms such as bacteria or viruses. 
Control over body movements. 
To help an individual better understand a situation or 
problem so that he or she can make decisions and take 
appropriate actions. 
Lack of or insufficient amount of. 
Identifying the disease which a patient has. 
Living thing which causes disease. 
Upset, disturbance. 
. 
A blood protein that stops bleeding. 
Bulk waste made by the body that leaves the body through 
the anus (bowel movement). 
The external sex organs. 
A type of sexually transmitted disease (STD) caused by a 
bacteria that can infect males and females, often without 
causing symptoms. If left untreated, may cause sterility. 
A hereditary clotting disorder characterized by excessive, 
sometimes spontaneous bleeding. 
hete.rosesual -
HIV-
A person who prefers sexual intercourse with someone of 
the opposite sex. 
Human Immunodeficiency Virus. This is the virus that 
causes AIDS. It has other names: HTLV-111. LAV. ARV are 
some. 
hom.osesual - A person who prefers sexual intercourse with someone of 
the same sex. 
immune- Resistance to a disease. 
immunodeficiency- Weakness of the immune system: the body cannot fight 
germs properly. 











Injected into a vein. 
A rare form of skin cancer which is common in persons 
with AIDS. 
Part of the immune system which can sometimes be felt 
near the surface of the body; "glands". 
Mistaken idea or incorrect notion. 
The soft. moist skin that lines the body cavities such as the 
mouth. vagina. urethra. eye.li~s. and r.ectum. 
Cancers and infections that invade a person whose 
immune system is weakened. 
Any living thing .. 
Inability to move. 
Liquid part of the blood which does not contain cells. 
pneumocystis carinii Severe form of lung infection commonly seen in AIDS 




Steps to prevent something. 
Frequent change of sexual partners or multiple sexual 
partners. 
A form of treatment for certain types of cancers using 
X-rays. 
• 
saliva- The clear liquid in the mouth, also called "spit". 
screen - To test, especially when testing a large number of people, 
such as all blood donors for HIV antibody. 
sexual partner - A person with whom another person has sexual 
intercourse. 
sexual intercourse- Sexual union with the penis in the vagina (vaginal sex), 
penis in the rectum (anal intercourse). or penis in the 
mouth (oral intercourse). 
si1n - Measured or objective evidence of a disease as determined 
by a physician. 
spermicide -
• 
A substance which kills sperm. Some spermicides may 
also kill viruses and bacteria. Certain spermicides may 
also kill the HIV. 
STD- Sexually transmitted disease caused by organisms which 
are usually transmitted person-to-person; including 
bacteria, fungi. protozoa, and viruses. 
symptoms- Changes in a person's health that can be seen or felt. 
Subjective evidence of an illness. 
syndrome - A paUern of signs and symptoms. 
syphilis - A sexually transmitted disease which can infect men. 
women, and unborn babies. If not treated, it can cause 
severe damage to many organs. 
syrinse - Holds substance to be injected. 
therapeutic - Useful in treating a disea.Se. 
transmitted - Passed from one person or place to another. 
urtne - Liquid waste matter of the body excreted by the kidneys, a 
yellowish. watery fluid. 
Tagina- ·The tube that leads from a woman's uterus (womb) to the 
outside of her body. Also called the birth canal. 
Ta&inal secretions - Fluids that can be found in the .vagina. 
Tirus - The smallest organism that can cause diseases. 
• 
ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) PREVENTION EDUCATION 
ADVISORY COMMITTEE 
Dr. Dan Ca.meron, Director Grace Lannert 
Sexually Transmitted Disease Division Broken Arrow Public Schools 
State Department of Education 
Frank Nichols 
Julie Conatser, Assistant Principal State Department of Education 
Norman High School 
Liz Parker 
Beth Dahl Oklahoma Congress of Parents 
State Department of Health and Teachers 
Gerald Daugherty, Superintendent Linda Pesterfield, Principal 
Seiling Public Schools Whitehead Public Schools 
Bishop John Hardt Clarita Porter 
United Methodist Church Yukon Public Schools 
Jimmie Heard, Superintendent Mary Reid 
Milburn Public Schools State Department of Education 
Bill Hicks, Principal Ron Roblyer 
Ponca City High School State Department of Education 
Greg Holleyman, Superintendent Pat Ross 
Wynona Public Schools Student Service Director 
Moore PubHt Schools 
Tom Hollingsworth 
State Department of Education Mary Spencer 
State Department of Education 
Claudean Hurley 
. 
Wewoka Public Schools Peg Vitek. Stillwater 
School Board Representative 
Dr. Greg Istre 
State Department of Health The Reverend Richard Virtue 
St. John's Episcopal Church 
Kay Jacobs 
State Department of Education Representative Vickie White 
·Norman 
Jennifer johnson, M.D. 
Children's Hospital Gae Wilson, Superintendent 
Glenpool Public Schools 
Kay johnson, Principal 
Flo"ffer Mound School 
Lyndol jones 
State Department of Health and 
State Department of Education 
AIDS Testin& Sites 
Anonymous AIDS testing is offered free of charge at these sites: 
AIDS Task Force 
Oklahoma Blood Institute 
1001 Lincoln Boulevard 
Oklahoma City, OK ( 405) 232-0670 
The Comanche County Health Dept. 
1010 S. Sheraton Rd., Lawton, OK 
(405) 248-5890 
The Garfield County Health Dept. 
2502 Mercer Dr., Enid, OK (405) 233-0650 
The Oklahoma City/County Health Dept. 
921 NE 23. OKC, OK (405) 427-8651 
The Tulsa City/County Health Dept. 
4616 E. 15th, Tulsa, OK (918) 744-1000 
• 
ToH Free Hotline: 800-312-AIDS--taped message; 800-147-AIDS--Counselor 
ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) PREVENTION EDUCATION 
EXPECTED OUTCOMES: 
1. Understand origin and history of Acquired Immune Deficiency 
Syndrome. AIDS was not recognized or described as a disease untill9Sl. 
The tracing of AIDS only began when doctors had seen enough of it to 
recognize that they were faced with a serious, previously unknown 
disease. In 1981, 316 people in the United States had AIDS. By june. l%7. 
there were over 35.908 reported cases of Acquired Immunodeficency 
Syndrome (AIDS) in the United States. Of these cases. about 145 were 
among teenagers (13-19 years old), and some 7.563 cases were among. 
young adults (20-29 years old). The incidence of AIDS continues to grow at 
an alarming rate. IT IS PROJECTED THAT BY THE END OF 1991. 270,000 
PERSONS WILL HAVE BEEN DIAGNOSED WITH AIDS IN THE UNITED STATES 
WITH A TOTAL OF 179,000 DEATHS. SEVENTY-FOUR THOUSAND CASES WILL BE 
DIAGNOSED AND FIITY-FOUR THOUSAND PEOPLE WILL DIE IN THAT YE.A..R 
ALONE! 
The exact origin of AIDS is not known. It is either a new human disease 
which developed recently, or it is a disease that was until recently isolated 
in a particular geographic group of people. There is much debate about 
where AIDS originated with some researchers suggesting it began in 
Africa. The disease was first noted in Africa in the late 1970's and early 
1980's, about the same time it came to attention in the United States. 
Eighty percent of people with AIDS have died within two years· of 
diagnosis. So far no one is known to have survived the disease for more 
than five years. 
There is no vaccine. no cure. and no treatment which actually stops the 
progression of the disease. The only sure method of slowing the expansion 
of AIDS is to prevent infection in the first place. To do this. people need 
clear and accurate information on AIDS, and if necessary, support in 
changing behaviors which could increase their likelihood of contracting 
the disease. 
Adolescents are at an age at which they are beginning to explore their 
sexual options and attitudes, may experiment with drugs and are 
establishing habits and behaviors they will carry into early adulthood. It 
is essential that youth have the necessary information to understand how 
AIDS is spread and how to prevent getting the disease. 
For teenagers. one of the best sources of information is their school. As a 
group, they are more likely to get good information about AIDS from 
thoughtfully taught classes than from newspapers. television. or radio. 
Teaching AIDS prevention is an essential part of a successful battle against 
the disease. It is important to have an ongoing parental involvement in 
AIDS education. Knowiedge of modes of transmission and methods of 
prevention is the main tool against the spread of AIDS. The goal is to 
·prevent the occurrence of future cases of AIDS in Oklahoma. (A more 
in-depth medical history of AIDS may be found in the appendices.) 
2. Define AIDS. AIDS is an abbreviation for Acquired Immune Deficiency 
Syndrome. AIDS is a life-threatening disease that damages the immune 
systems of otherwise healthy persons. ( 1) 
Acquired means that AIDS is not inherited, but rather is passed from 
person to person. 
Immune refers to the body's natural mechanism to protect itself from 
disease. 
Deficiency means that the immune system is not working. 
Syndrome indicates that a pattern of symptoms has developed. ( 1) 
3. Name the cause of AIDS. Acquired Immune Deficiency Syndrome 
. (AIDS), identified in 1981. is caused by a virus that attacks the body's 
immune system. Many rare infections and cancers can then attack the 
defenseless body. Many of the infections and cancers are treatable, but 
the underlying immune problem is not. The virus is called Human 
Immunodeficiency Virus CHIV). ( 1) 
4. List the methods of transmission of AIDS. People do not become 
infected with the HIV in day-to-day, casual contact with family,' friends. 
acquaintances, or the population at large. unless that contact involves 
sexual encounters or the sharing of needles or syringes from intravenous · 
drug use contaminated by an infected person. 
The virus that causes AIDS lives in certain body fluids, especially blood and 
semen. People most commonly become infected with HIV after their blood 
system has come into direct contact with the semen. blood, or vaginal 
secretions of someone else ·who is infectious. Although the HIV has been 
isolated from other body fluids such as saliva. tears. perspiration, or .urine. 
transmission has never been proven to have occurred in contact with 
these. 
Transmission occurs through: 
a. Sexual contact--male to male, male to female. female to male--often 
with several persons. and most commonly in the form of anal 
intercourse. as has usually been the case in homosexual men. 
(777. of reported cases) (4) 
b. Shared use of needles or syringes for intravenous drug use (and 
possibly the use of nonprofessional tattoo needles). 
(17t. of reported cases) (1) (3) (4) 
c. F.rom infected mother to child befo.re or during birth. ( 1) 
d. Contact with contaminated blood products. (4) 
5. List the methods of prevention. 
·AIDS prevention education sh~ll specifically teach students 
that engaging in homosexual activity. promiscuous sez:ua.l 
activity. intravenous drug use or contact with contamin.&.ted 
blood products is nov known to be primarily responsible for 
contact with the AIDS virus: Title 70 O.S. 1987 Supp S 11-103.3 
a. Abstinoncc. Practice abstinence. Since HIV can be transmitted by 
either heterosexual or homosexual intercourse. the avoidance of sexual 
intercourse is the most effective manner of not contracting or 
spreading the HIV. Abstinence from sexual activity is the only certain 
means for the prevention of the spread or contraction of the HIV 
through sexual contact. Learn to say "NO!" (4) 
b. Artificid means of Birth Control. Know that artificial means of 
birth control such as condoms and spermiddes are not a certain means 
of preventing the spread of the HIV and reliance on such methods puts 
a person at risk for exposure to the disease. Sexual intercourse, with or 
without condoms. with any person testing positive for human immuno-
deficiency virus antibodies, or any other person infected with the HIV, 
places that individual in a high risk category for developing AIDS. 
(4) 
c. Don't share needles and syringes. Sharing needles and syringes 
to inject heroin. cocaine, and other drugs is directly related t.o the risk 
of getting AIDS. , 
All drugs and alcohol reduce the ability of the body to resist infection. 
More importantly, drugs and alcohol may alter the user's judgment, 
making the person more likely to participate in sex activities. 
d. Promote blood supply safety. Persons in high risk groups should 
not donate blood. Because of sophisticated screening and processing, 
the chances are about one in one million of getting AIDS from a blood 
transfusion. A person cannot contract AIDS while donating blood 
because new and sterile equipment is used. 
6. List and describe the forms of the HIV infections. 
a. :No Sisns. Some people remain apparently well after infection with 
the HIV. They may have no physically apparent symptoms of illness. 
These infected individuals can spread the virus to others through 
sexual intercourse or sharing needles. Anyone who thinks he or she is 
infected or involved in high risk behaviors should not donate his or 
her blood, organs. tissues. or sperm because they may now contain the 
HIV. 
b. ARC. AIDS-Related Complex (ARC) is a condition caused by the HIV in 
vhich the patient tests positive for HIV infection and has a specific set 
of clinical symptoms. However. ARC patients' symptoms are often less 
severe than those with the disease called classic AIDS. Signs and 
symptoms of ARC may include loss of appetite, weight loss. fever. night 
sweats. diarrhea, tiredness, lack of resistance to infection, or swollen 
lymph nodes. These are also signs and symptoms of many other 
diseases and a physician should be consulted. 
c. AIDS. Only a qualified health professional can diagnose AIDS. which 
is the result of a natural progre~s of infection by the HIV. AIDS 
destroys the body's immune (defense) system and allows otherwise 
controllable· infections to invade the body and cause additional 
diseases. These opportunistic diseases would not otherwise gain a 
foothold in the body. These opportunistic diseases may eventually 
cause death. A woman who is infected with the HIV and becomes 
pregnant. is more likely to develop ARC or classic AIDS. 
Some symptoms and signs of AIDS and the "opportunistic infections'' 
may include a persistent cough and fever associated with shortness of 
breath or difficult breathing. These may be the symptoms of 
pneumocystis carinii pneumonia. Multiple purplish blotches and 
bumps on the skin may be a sign of Kaposi's sarcoma. HIV in all 
infected people is essentially the same; the reactions of individuals 
may differ. 
-
d. Lons term.. The HIV may also attack the nervous system and cause 
delayed damage to the brain. This damage may take years to develop 
a.nd the symptoms may show up as memory loss, indifference, loss of 
coordination. partial paralysis. or mental disorder. These symptoms 
may occur alone. or with other symptoms mentioned previously. (2) 
7. Identify tests for the HIV infections. As with most other infections. 
there is no single. test for diagnosing AIDS. There is now a test for 
antibodies (substances produced in the blood to fight disease organisms) to 
the virus that causes AIDS. Presence of the HIV antibodies means that a 
person has been infected with the HIV. The antibody test is used to screen 
donated blood and plasma and to assist in the prevention of cases of AIDS 
that result from blood transfusions or the use of blood products, such as 
Factor VIII. needed by people with hemophilia. The test is available 
through private physicians and community organizations. The Oklahoma 
State Department of Health has established testing sites in five County 
Health Departments for people who feel they may .have been exposed to 
AIDS. Counseling before and after the test is available at these sites. Test 
results will not be given over the telephone. (A list of these testing sites is 
given in the appendices.) (1) (3) 
8. Describe methods of care and treatment. Casual contact with AIDS 
patients o.r persons who might be at risk for the illness does NOT place 
others at risk for getting the illness. No cases have been found where 
AIDS has been transmitted by casual household contact with AIDS or 
persons at high risk for getting the illness. Although the HIV has been 
found in saliva. there have been no cases in which exposure was shown to 
have resulted in transmission. Ambulance drivers. police. and fire-
fighters who have assisted AIDS patients have not become ill. Nurses, 
doctors. and health care personnel have not developed the HIV infection 
from caring for persons with the HIV. except when care givers have been 
in direct contact with the HIV. 
Everyone should follow safety procedures carefully when handling blood 
and tissue specimens from persons with potentially transmissible diseases, 
including AIDS. School districts shoulit also have guidelines for dealing 
with accidents involving blood or other body fluids to prevent the spread 
of the disease. 
Currently there are no antiviral drugs available anywhere that have been 
proven to cure AIDS. although the search for such a drug is being pursued 
vigorously. Some drugs like azidothymidine (Alf) have been found that 
inhibit the virus. but they do not cure the infection. Though no treatment 
has yet been successful in restoring the immune system of an AIDS 
patient, doctors have had some success in using drugs. radiation, and 
surgery to treat the various .illnesses of AIDS patients. Therapeutic agents 
are needed for all stages of AIDS infections. to block action of the virus 
once infection has occurred. and to build up immunity in patients who 
have developed AIDS symptoms. "(3) 
9, Li:Jt the sroups at high ri:~k for acquirins the HIV infection. 
AIDS does not discriminate by race, sex. or age. Although the initial 
discovery was in the homosexual community, AIDS is not a disease only of 
homosexuals. AIDS is found in heterosexual people as well. AIDS is not just 
a male disease. AIDS is found in women; it is found in children. AIDS is 
found in all races. In the future AIDS will probably increase and spread 
among people who are not homosexual or intravenous drug abusers in the 
same manner as other sexually transmitted diseases like syphilis and 
gonorrhea. 
a. Men Yho have sexual relations with other men are 
especially a.t rist:. About 70 percent of people with AIDS 
throughout the country are male homosexuals and bisexuals. This 
percentage probably will decline as heterosexual transmission 
increases. Infection results from a sexual relationship with an 
infected person. 
The risk of infection increases according to the number of sexual 
partners one has, male or female. The more partners you have, the 
greater the risk of becoming infected with the HIV. 
b. Drug abusers who inject drugs into their veins are another 
population group at high rist and with high rates of 
infection by the HIV. Users of intravenous drugs make up 25 
percent of the cases of AIDS throughout the country. The HIV is 
carried in contaminated blood left in the needle. syringe, or other 
drug-related implements and the virus is injected into the new victim 
by reusing dirty syringes and needles. Even the smallest amount of 
infected blood left in a used needle or syringe can contain live HIV to 
be passed on to the next user of those dirty implements. 
c. Some persons Yith hemophilia (a blood clotting disorder 
that mates them subject to bleeding) have been infected 
Yith the HIV either through blood transfusion or the use of 
blood products that help their blood clot. Now that we know 
how to prepare safe blood products to aid clotting, this is unlikely to 
happen. This group represents a very small percentage of the cases of 
AIDS throughoutthe country. 
d. Some people .may have had a blood transfusion prior to 
March. 193:) before blood was screened for safe transfusion 
and .may have beco.m.e infected with the HIV. Blood that has 
been collected for use is tested for the presence of antibody to the HIV. 
Fortunately, there are not now a large number of these cases. With 
routine testing of blood products fo.r antibody to the HIV. the blood 
supply for transfusion is now safer than it has ever been with regards 
to AIDS. Persons who have engaged in homosexual activities or have 
injected street drugs since 1977 should never donate blood. If they 
admit to such activities, they are not allowed to donate. 
e. Heterosexual partners of persons infected Yith the HIV also 
are at high risk for developing HIV infections. As of now, 
most cases of heterosexual-acquired cases of AIDS have occurred 
among sex partners of intravenous drug users. HIV infection occurs 
from male to male, male to female, or female to male sexual contact. 
f. Children born to HIV-infected mothers, may be infected. The 
mother can pass the HIV to her unborn child. Approximately one third 
of the babies born to AIDS infected mothers will also be infected with 
the HIV. Most of the infected babies will eventually develop the disease 
and die. Several of these babies have been born to wives of 
hemophiliac men infected with the HIV by way of contaminated blood 
products. Some babies have also been born to women who became 
infected with the HIV by bisexual partners who had the virus. Almost 
all babies with AIDS have been born to women who were intravenous 
drug users or the sexual partners of intravenous drug users who were 
infected with the HIV. More such babies can be expected. (2) 
10. Understand that a Yoman Yho is infected Yith the BIV and 
becomes presnant, is .more likely to develop ARC or classic 
AIDS. Studies have shown if a woman is infected with HIV. and becomes 
pregnant, she is twice as likely to develop classic AIDS. 
11. Identify misconceptions about AIDS. There are no known medically 
documented cases caused by: 
a. donating blood 
b. sharing food or drinks 
c. touching or hugging someone 
d. insect bites 
e. riding buses 
f. toilet seats 
g. sinks 
h. swimming pools 
i. hot tubs 
j. drinking fountains 
k. sharing telephones 
1. sharing p~ncils 
m. sharing paper 
n. from someone coughing or sneezing on you 
o. shaking hands 
p. sharing tools 
q. social kissing 
r. crying 
s. sharing bed linens, towels, cups, straws. dishes, or any other 
eating utensils 
t. doorknobs 
u. office machinery 
v. household furniture 
(1) (2) (3) 
12, Identify authoriiative sources of inCorm.ation about AIDS used 
in the development of this publication. 
(1) • AIDS Update• pamphlet distributed by Oklahoma State Department 
of Health, 1000 NE lOth, Oklahoma City, Oklahoma 73152. 
(2) Surgeon General's Report on Acquired Immune Deficiency 
Syndrome distributed by the U.S. Department of Health and Human 
Services. 
(3) AIDS Acquired Immune Deficiency Syndrome, Junior High 
School Program, Dade County Public Schools, Miami. Florida. 
(.f) Title 70 O.S. 1987 Supp. § 11-103.3 (A complete copy of this 
legislation is found in the appendices.) 
AIDS EDUCATION RESOURCES 
GRADES :5-6 . 
AREAS OF EMPHASIS 
General Information 
* Transmission-symptoms ,.. ,.. Prevention 
* * * Societal Impact 
TYPE OF RESOURCE VENDOR ,.. ... ,.. * 
PRINT RESOURCES 
About AIDS (booklet) Scriptographic X X X 
~h22~ine; G22!J H~ilth Scott X X 
(texts, tests, posters) Foresman 
HONPRINT RESOURCES 
Al..l2£ (video) SVE X 
AIDS: The Facts (video) Guidance Assoc. X X X 
Idangle of Health (filmstrip) Walt Disney X X 
AIDS EDUCATION RESOURCES 
GRADES 7-9 
AREAS OF EMPHASIS 
General Information 
* Transmission-symptoms 
* * Prevention 
* * * Societal Impact 
TYPE OF RESOURCE VENDOR * * * • 
PRINT RESOURCES 
About AIDS (booklet) Scriptographic X X X X 
Ab2Yt All2S and Sh22tini 12rYi~ Scriptographic X X X 
(booklet) 
AIDS. (pamphlet) Amer. Red Cross X X 
AIDS. (posters) Amer. Red Cross X X X 
AIDS: Beyond Fear (booklet) Amer. Red Cross X X X X 
AIDS: The Facts (pamphlet) Amer. Red. Cross X X 
:NONPRINT RESOURCES 
AIDS. (video) SVE X 
A!IlS: A~qyir~g Immyn~ Walt Disney X X X X 
Deficiency Syndrome (film) 
AIDS: B~yQng E~ar <video) Amer. Red Cross X X X 
AIDS EDUCATION RESOURCES 
GRADES 10-12 
AREAS OF EMPHASIS 
General Information 
* Transmission-symptoms 
* * Prevention 
* * * Societal Impact 
TYPE OF RESOURCE VENDOR * * * * 
PRINT RESOURCES 
About AIDS (booklet) Scrip to graphic X X X 
Ab2u~ AIDS and Shooting Drug~ Amer. Red Cross X X X 
(booklet) 
AID.S. (poster) Amer. Red Cross X X X 
AIDS--Beyond Fear (brochure) Amer. Red Cross X X X 
AIDS: The Facts (pamphlet) Amer. Red Cross X X X 
AIDS, Sex and You (pamphlet) Ain.er. Red Cross X X X 
C2Dins With AII2S (pamphlet) R. I. Dept. .of X X X X 
Health 
£a&~ Ah2Yt AIDS (pamphlet) Office of X 
(Spring, 1986) Public Affairs 
£~~~ Ah2Yt AIDS (pamphlet) R. I. Dept. of X X X 
Health 
£a&~ Ab2Yt AIDS and I!ru& AbY~~ Amer. Red Cross X X X 
(pamphlet) 
SYU~QD. G!iln~ral' ~ R~D2rt QD. R. I. Dept. of X X X X 
A.lN (pamphlet) - Health 
Wh~n a:Ed~ng Has AII2S . R. I. Dept. of X X 
(pamphlet) Health 
Grades 10-12 
TYPE OF RESOURCE VENDOR 
HONPRI:NT RESOURCES 
AIDS. (video) SVE 
AREAS OF EMPHASIS 
General Information 
i': Transmission-symptoms 
11' i': Prevention 
11' i': 11' Societal Impact 
i': 1t i': 1t 
X 
AIDS: Acguired Immune Walt Disney X X X X 
Deficiency SyndromeUilmstrip) 
AIDS: Beyond Fear (video) Amer. Red Cross X X X X 
AIDS: The Disease and 
What We Know (video) 
The AIDS Moyie 
AIDS. Sex and Dru as {video) 
AIDS - What Everyone Needs 
to Knoy (film) 
Profile of an Epidemic (video) 
OTHER RESOURCES 
Sunburst X 
New Day Films X X X X 
Amer. Red Cross X X X X 
Churchill.Films 
R.I. Dept. of 
Health 
X 
X X X X 
AIDS Educa.t.ion for Youth (video) Amer. Red Cross X 
AIDS: Learn for Your Life All Media Prod. X 
(video) 
AIDS: The Plaaue Tha.tKnoys No Reader's Digest X 
Boundaries (special report--
June, l987)(question and 
answer guide available) 
AIDS: What Youna Adults Should Amer. Alliance X 
~ (student and instr. guide) 
Schools Without Druas: The 
Challenae 
U.S. Dept. ofEduc. X 
TEACHER RESOURCES 
PRINT RESOURCES 
About AIDS and Shooting Drugs (booklet) 
AIDS (guide) 
AIDS: 100 Questions and Answers (article) 
AIDS and Children: Information for Teachers 
and School Officials (brochure) 
AIDS and the Salety of the Nation's Blood Supply 
AIDS and Your Job--Are There Risks? 
AIDS: Deadly But Hard to Catch (article) 
AIDS in Children: A Review of Clinical 
Epldemloioglc and Public Health Aspects (article) 
AIDS Instruction and Local Control (article) 
AIDS Instruction Becomes a Troubling Test 
of Courage for Local School Boards (article) 
The AIDS Movie 
AIDS: Protect Your Health, Know the Faets (brothure) 
AIDS Update (brochure) 
AIDS: What You Need to Know, What You 
Should Do (article) 
Answers about AIDS (brochure) 
VENDOR 
Channing L. Bete Company 
Dade County Florida 
Oklahoma State Department of Health 
American Red Cross, U.S. Public Health 
OK County Chapter 
323 N.W. lOth 
Oklahoma City, OK 73102 
American Red Cross, U.S. Public Health 
OK County Chapter 
323 N.W. lOth 
Oklahoma City, OK 73102 
American Red Cross, U.S. Public Health 
OK County Chapter 
323 N.W. lOth 
Oklahoma City, OK 7~102 
Consumer Reports (November, 1986) 
U.S. PubHc Health 
Wall Street journal (May, 1987) 
American School Board Journal 
(March, 1987) 
New Day Films 
Wisconsin Division of Health 
Oklahoma State Department of Health 
U.S. News and World Report 
(January 12. 1987) 
American Council on Science and Health 
Bibliography on Boots Available on AIDS (bibliography) Pamela Sidnell 
Federal Guidelines for AIDS Courses Stress 
Abstinence (article) 
Guidelines for Implementing the Critical 
Health Problems and Comprehensive 
Health Education Act (article) 
If Your Test for Antibody to the AIDS Virus 
· Is Positive ... (brochure) 
Impairment Due to Infectious Disease Ruled 
A Handicap: Supreme Court Decision as 
Applying to AIDS (article) 
Lo Que Todos Deben Saber Sobre El Sida (booklet) 
(Everything You Need to Know About AIDS) 
More Help for Your Fight Against AIDS (article} 
Network Publications (catalog) 
Preventing Aids Through Education (brochure) 
Some Questions and Answers About HIV 
Infections and AIDS (brochure) 
Surgeon General's Report on AIDS (pamphlet) 
Teaching AIDS (resource guide) 
What Parents Should Know About AIDS (article) 
Education Week (March 25, 1987) 
Illinois Department of Education 
American Red Cross, U.S. Public Health 
Education Week (March 11. 1987) 
Channing L. Bete Company • 
American School Board journal 
Network Publications 
Minnesota Department of Education 
American Social Health Association 
U.S. Public Health Service 
Marcia Quackenbush andPamela Sargent 
PTA Today (February, 1987) 
DIRECTORY OF VENDORS 
tiJ.mt Address City, State. Zio ~ 
All Media Productions Education Division Grand Rapids, Ml 4950 I 616-459-9703 
142"1 Lake Dr. SE 
Suite 222, Box K 
Amer. Alliance for Health 1900 Association Dr. Reston, VA 22091 
American Cancer Society 10 Main St. Pawtucket, R.I. 02860 
American Red Cross OK County Chapter Oklahoma City, OK 73102 
323 N.W. lOth 
Amer. Social Health Assoc. 260 Sheridan A venue, Palo Alto CA 94306 
Suite 307 
Center for Disease Control AIDS Activity Atlanta, GA 30333 800-342-AIDS 
Bldg. 6, Room 292 
1600 Clifton Rd. 
Channing L. Bete Company See Scriptographic Booklets 
Churchill Films 662 W, Robertson· Blvd. Los Angeles, CA 90069 800-334-7830 
Dade County Public Schools School Board Admin. Miami, FL 33132 
1450 N.E. Second Ave. 
Guidance Assoc., Inc. Communications Park Mount Kisco, NY 800-·431-1242 
Box 3000 10549-0900 
Illinois State Board of Educ. · 100 N. First St. Springfield, IL 62777 
Minnesota Dept. of Health 7 17 Delaware St. S.E. Minneapolis, MN 55440 
Network Publications P.O. Box 1179 Santa Cruz, CA 95061-1479 
New Day Films 22 Riverview Dr. Wayne, NJ 07470 201-633-0212 
Ohio Dept. of Health Div. of Epidemiology Columbis, OH 43266-0118 614-466-5480 
AIDS Activities Unit 246 N. High St. 
OK State Dept. of Health l 000 N.E. 1Oth Oklahoma City, OK 73152 
R.I. Dept. or Health 75 Davis St. Providence, R.I. 02908 
Scott Foresman &: Co. 4432 Baxter Dr. Oklahoma City, OK 73120 
Scriptographic Booklets Channing L. Bete, Co., South Deerfield, MA 0 1373 
Inc., 200 State Rd. 
Pamela Sidnell Rosenburg Library Galveston, TX 77551 
Society for Visual Educ., Inc. Department BK Chicago, IL 60614-1299 
(SVE) 13i5 Dlversey Partway 
Sunburst Communications Room TJ7 Pleasantville, NY 800-431-1934 
39 Washington Ave. 10570-9971 
Texas Department or Health 1100 W. 49th St. Austin, TX 78756-3199 
_Texas Medical Association 1801 N. Lamar Rd. Austin, TX 7870 I 512-477-6704 
U. S. Dept. of Education Washington, D.C. 20202 202-732-4 I 6 I 
Walt Disney 500 S. Buena V lsta St. Burbank, CA 91521 800-423-2555 
Walt Dls.ney Ed. Media Catalog Customer Service Kansas City, MO 64153-9990 
103 N.W. Praire View Rd. 
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Acquired Immunodeficiency Syndrome: 
Review of ~pidemiology 
H. DAN CAMERON, JR., MPH 
The AIDS epidemic began in relative obscurity with 
initial disease reports to the Centers for Disease Con-
trol in June 1981. By August 1985, over 12,000 cases have 
been reported. The total cases have doubled in the 
past year, with public concern and scientific knowledge 
of the disease increasing at even greater rates. This 
article will review the epidemiology of AIDS, current 
statistics, and public health intervention programs. 
The acquired immunodeficiency syndrome (AIDS> was first described during the spring of 1981. The 
Centers for Disease Control (CDC) published the first 
recognition of an unusual pattern of disease in young 
homosexual men during June and July 1981.1'2 These 
initial reports of 26 patients with Kaposts sarcoma 
and 15 patients with Pneumocystis carinii pneumonia 
spurred the subsequent reporting of an additional 70 
cases within six weeks.=~ 
Surveillance for this apparently new syndrome was 
initiated in June 1981, reaching 1,000 reported cases 
by February 1983. By August 1985, over 12,000 cases 
hod been reported, twice the total of just one year ear-
lier. Public concern has increased at a rate comparable 
to the increase of reported cases. A significant fatality 
rate and the potential for disease transmission through 
blood or blood products has fueled the increasing public 
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demand for research and control measures by public 
health agencies. 
This article will review the epidemiology of AIDS 
Within the United States and in Oklahoma. The geo-
graphic distribution and patient characteristics are re-
markably similar between this state anq the nation. 
A companion article4 will describe the clinical manifes-
tations and management of the AIDS patient. 
Case Definition 
The case definition for AIDS was established by the 
CDC for the purpose of disease surveillance. The pri-
mary criteria are: (1) The presence of a reliably diag· 
nosed disease at least moderately indicative of cellu-
lar immune deficiency and (2) the absence of an un-
derlying cause for the immune deficiency or of any 
defined cause for reduced resistance to the disease. 
A serologic test for antibodies to the virus has been 
added to the surveillance criteria. In spite of this, 
the definition remains primarily clinical and is 
further discussed in the accompanying article.• 
Disease Trends 
Cases of AIDS reported in the United· States and 
Oklahoma are presented in the figure. The epidemic 
curve for the United States shows a sharp increase 
in reported cases over the past four years. The first 
case of AIDS in Oklahoma was reported in January 
1983 and reporting has not increased as dramatically 
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Figure.-Reported AIDS cases in Oklahoma ~nd the United States by 
six-month periods 1979·1985. 
total of 26 cases were reported in persons with onset 
of symptoms occurring while they were living in 
Oklahoma. Physicians have reported an additional 
15 cases among Oklahoma residents whose onset of 
symptoms occurred while the individuals were rcsi· 
dents of another state. Most frequently, these latter . 
patients have returned to Oklahoma to be closer to 
family after a diagnosis of AIDS .in California (6 pa· 
tients) and New York (4 patients). Of the 41 total 
cases, 28 have died. The 68% mortality reported in 
Oklahoma is higher than the nationally reported 
mortality rate of 50% (6,481 deaths among the total 
12,932 reported cases) through September 2, 1985. 
Among those who died, the average time from 
date of diagnosis to date of death has been 5.6 months 
in Oklahoma. Those patients returning to this state 
after a diagnosis of AIDS had an average of 8.2 
months. Differences may be attributable to a selec-
tion bias, as more severe cases may not survive long 
enough to make the transition to another state. 
Geographic Distribution 
· The majority of cases are reported from larger met-
ropolitan areas, primarily New York City, San Fran-
cisco, and Los Angeles (Table 1 }. Distribution of cases 
by state reveals 36% of the cases have been reported 
in New York and 23':-f, in California, with .Florida, 
New Jersey, and Texas ranked third through fifth 
respectively. In Oklahoma, 34% of the cases are r~ 
ported from the 'fulsa metropolitan area and 50% 
from the Oklahoma City metropolitan area. 
Risk Characteristics 
Distribution of individuals within the identifiable 
risk groups has remained fairly constant since the 
first 1,000 cases were reported. Table 2 presents the 
major patient characteristics listed as a hierarchy of 
mutually exclusive groups. Data for Oklahoma 
closely resemble the national trends, with homosex-
ual or bisexual men representing the majority (73%) 
of cases. The second major group (17%) consists of 
intravenous drug ubuscn;. 
Age distribution is clustered in the third decade 
of life, with a mean age in Oklahoma of 35 years. 
Comparison of age distribution for Oklahoma and 
the nation is pres~nted in Table 3. 
Racial and ethnic distribution in the United 
St.ates and Oklahoma has remained fairly constant. 
Differences betweep Oklahoma trends and national 
trends may be attributed to relative differences in 
racial makeup of the primary reporting cities. Okla-
homa has reported 21 cases in whites (81 %) and 5 
cases in blacks (19%). Nationally, 60r:*, of cases have 
been in whites and 25% in· blacks. · 
The vast majority of cases oq:ur in males. Al-
though 100% of Oklahoma cases are male, 93% of 
nationally reported cases arc male. 
Transmission Patterns 
Initially, the des~ribed patterns of infection were re-
markably similar to those of hepatitis B infection 
and suggested a similarly transmissible agent. Risk 
of infection increases with the number of sexual 
partners.s-7 While the greatest risk occurs among 
homosexual or bisexual men, heterosexual transmis-
sion has occurred.K.s 
Drug abuse is second in the hierarchy of risk 
characteristics. Use of inhalant drugs such as amyl 
and butyl nitrite is associated with AIDS; however, 
it appears to be a coincidental association with fre-
quent receptive anal intercourse. 10" 1~The use of paren-
teral drugs has been implicated and the primary risk 
appears to be the sharing or reuse of contaminated 
needles. 1" Greatest risk from this activity is reflected 
by incidence in New York City and New Jersey where 
"shooting galleries," apartments, or other secure lo-
cations frequented by addicts are greatest in number. 
OKLAHOMA STATE MEDICAL AsSOCIATION 
Hemophiliacs have been at increased risk for 
AIDS duo to trentment of their diseuse with concen-
trated clotting factors derived from pooled plasma. 
A single lot of this clotting factor concentrate is pro-
duced from donations of 2,500 to 25,000 commercial 
donors. Recipients of Factor VIII concentrate began 
to show seropositivity to human T-celllymphotrophic 
virus type III {HTLV-lll) antibody in 1979, with sub-
stantial increases in antibody prevalence during the 
past six years. 14 Recommendations to replace therapy 
with heat-treated concentrates should significantly 
reduce the risk of AIDS among hemophiliacs. 
Transmission of AIDS by blood transfusion or use 
of blood products was first reported in December 
1982. 16 This led to the March 1983 Public Health 
Service recommendations advising members of 
groups at risk for AIDS to refrain voluntarily from 
donating blood. 11 Relatively long intervals, some-
times exceeding four years, between a suspect blood 
transfusion and subsequent diagnosis of AIDS in the 
transfusion recipient have been '"reported. 17 This 
suggests that the impact of voluntary donor deferral 
might not be evident for several years. The availabil-
ity of a serologic test in March 1985 should further 
enhance the safety .of the blood supply and virtually 
elimina~e transfusion-associated AIDS cases in the 
future. 
Table 1. -All AIDS Cases Per Million Population (from the 
1980 Census), by Standard Metropolitan Statistical Area 
(SMSA) of Residence, Reported from June 1, 1981 to September 
2, 1985 - United States 
Cases 
SMSAof Percentage ~rmillion 
residence Cases of total population 
NewYork,NY 428& 33 469.9 
. San Francisco, CA 1463 11 450.1 
Miami,FL 430 3 264.5 
Newark, NJ 319 2 162.3 
lo5 Angeles, CA 1092 8 146.0 
Elsewhere 
(irrespective o( 
SMSA! ....lli1 ~ ~ 
Totod-
United States 12932 100 56.3 
Oklahoma City, OK 13 so 15.6 
Tulsa, OK 9 35 13.1 
Elsewhere __ 4 ~ _bZ 
Total-Ok~hom.a 26 100 8.6 
Soul<...-: A<.quort'd ~oc:imcy Syndlornoo ~lv S...V...II.>ne~ I!I!IXJit- UnrtP<I 
SIW-.. AIDS A<:hvol'f. Ctnto."R fo< Do"'.no! Cl)fliTOI.  2, 1'1115. 
OloW>orm AIDS~ repnnood 10 5<-xuolly rr.....,..ned Do wow o;VTWOn, Oldohamlo 
SC. ~ ol t~•hll, /wtiW J I, 1985. 
JouRNAL 1 JANUARY 198& 
Acquisition of AIDS by infants and children oc-
curs by two predominant. routes: (1) Infection ns a 
result of blood transfusion or blood products, and (2) 
infection as a result of birth to a mother who has 
AIDS or is in a high-risk category. 111 Transmission to 
infants by an infected mother appears to occur in 
utero, but does not necessarily oecur in all sub-
sequent births.111 Transfusion-associated cases in chil-
dren have shorter intervals - 8 months - between 
transfusion and onset of symptoms, when compared 
to adults.20 
Transmission by casual person-to-person contact 
has never been shown to occur. There are no 
documented cases of transmission to household non-
sexual contacts of AIDS victims. 
Etiology 
The variety of factors that contribute to the risk 
characteristics and occurrence of disease in recipients 
of blood suggests the existence of a transmissible 
agent. 21 In Paris, isolation of a new human retrovirus 
from a homosexual male experiencing persistent lym-
phadenopathy was reported in 1983 a5 lym-
phadenopathy-associated virus <LA V). 22 The identifi-
cation of an apparently similar virus in the United 
States was reported in 1984 and labeled as human 
T-cell lymphotrophic virus type III23"25 or AIDS-as-
sociated retrovirus (ARV).26 The HTLV-III infects and 
kills T-lymphoeytes called helper cells. Several 
studies have reported population groups with a high 
percentage of individuals with seropositivity for 
HTLV-III antibody, though current prevalence of 
AIDS is low::7 •2"~ these observations suggest that host 
defenses against this virus may exist. 
This virus has been isolated from semen, blood, 
saliva, tears, and lymph nodes of infected individu-
als.22"24'29"31 Greatest risk of transmission appears to 
relate to blood and semen. Transmission by saliva 
and tears has not been demonstrated. Further r~­
search may clarify the mechanism of disease develop-
ment more precisely. A potential for cofactors in dis-
ease development has been suggested.32 While addi-
tional research will expand the knowledge surround-
ing the development of AIDS, adequate information 
already exists to establish some effective control 
measures. 
Serologic Testing 
The Food and Drug Administration (FDA) licensed 
the first serologic test for HTLV-III antibody on 
March 2, 1985. An enzyme-linked immuncsorbent 
assay (ELISA) is both highly sensitive (97.3%) and 
Blood Banking specific (98.6%).:13 Specificity can be further con-
finned using a Western Blot electrophoresis tech-
nique.:w These assays are being applied for confirma-
tion of clinical diagnosis, for screening of blood prod-
ucts, and for epidemiologic purposes. However, it 
must be stressed that these are not tests for AIDS. 
These tests identify antibodies to HTLV-III, indicat-
ing only that an individual has been exposed to the 
virus and may be potentially infectious. It appears 
that a minority of seropositive patients develop 
AIDS.35 
l<bllowing l<'DA licensure of an ELISA, the blood 
banking community began a nationwide effort to test 
all units of blood donated within the United States. 
Notification of the blood bank donors with positive 
tests is made only after repeatedly positive ELISAs 
(two tests of the specimen to eliminate nonspecific 
reactions) and confirmation by Western Blot. Plasma 
centers may notify a donor prior to availability of 
the Western Blot results since these individuals tend 
to donate more frequently. 
. . 
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Nationally, reports from American National Red 
Cross indicate 1,593,969 units have been tested, ond 
3,209 (0.20%) were found repeatably positive for 
HTLV-III antibody from March through June. Okla-
homa blood banks have tested 77,445 units through 
August 1985 and found 171 units (0.22%) repeatably 
positive. 
Public Health Intervention 
Public health intervention begins with an accurate 
description of the disease morbidity and mortality. 
The extend of AIDS morbidity and mortality has 
brought this epidemic to national attention. The pub-
lic concern has been that an uncontrollable epidemic 
will spread to the general population and not remain 
limited to the recognized risk categories. The toll on 
society has been great, even though limited within 
a few high-risk categories. 
Oklahoma began development of an AIDS pro-
gram with the establishment of AIDS as a reportable 
disease in July 1983. Surveillance includes the volun-
tary reporting by physicians of patients with AIDS. 
This cooperative relationship between public health 
personnel and practicing physicians is crucial to an 
accurate description of the extent of the problem in 
Oklahoma. 
Sites have been established to provide testing for 
HTLV-III antibody to individuals in high-risk 
categories and to persons concerned about possible 
exposure to AIDS. These "alternative" testing sites 
were established to further safeguard the blood sup-
ply. They allow individuals to be tested without 
donating blood and provide strict confidentiality to 
persons tested. 
While an effective treatment or cure for AIDS is 
not currently available, control programs can have 
an impact through professional and public education. 
The potential for spread of this epidemic beyond the 
recognized risk groups in the United States. is real. 
Transmission of this disease in homosexual and 
bisexual men appears to be related to sexual promis-
cuity among members of these groups. In Africa, the 
same disease, apparently, is frequently spread among 
promiscuous heterosexual populations.;J6..:lK Success." 
ful control measures may depend on the ability to 
modify sexual behavior through public education ef-
forts. Selected stu_dies have reported modifications in 
sexual behavior among homosexual and bisexual 
men,~9 and changes can be measured by the reduction 
of associated diseases, such as reports of rectal 
gonorrhea in San Francisco. Knowledge of risk is not 
always enough to effect behavior modification, as 
"WJie 3.-Age Distribution ........ OklmocN ~nd United St~tes 
Oldahoma United Sl~tes 
A,;e c~~es (')(.) C»n (%) 
UndertJ - (-) 165 (1) 
13- 19 - (-) 61 (0) 
20-29 8 (Jl) 2726 (21) 
30-39 13 (SOl 6069 (47) 
40-49 2 (8) 2701 (21) 
Over 49 .J. .J.!ll ~ _.{2! 
Total 26 (100) 12932 (100) 
(Mean age 
35 years) 
Source: Acqui~ lmmunodo-lic;,ncy Syndmmr w.-ftly Surwillanc~ ~-Umlfti 
SC.Ir-l. AIDS Nlivitv, C~ll'n lnr o;.,..,,,.. Conoml. SP.pt"""~ 2, 1'!85. 
OklohorN AIDS C•wo ~t!'d 10 S"~tly Tr•l11lnl~ Oi-to! Oiv~ion. Okb-
homa Sl.lll! ~ ol He.allll, Au1!W 31. 19tl5. 
demonstrated by seat-belt use and alcohol consump-
tion, but further research into educational methods 
may improve the public response in AIDS risk-reduc-
tion efforts. 40 
The pervasive nature of public concern over AIDS 
has ex·tended the boundaries beyond the initial con-
cern with high-risk groups. Careful and deliberate 
pianning is necessary to establish recommendations 
or guidelines for situations where legitimate con-
cerns for disease transmission exist. Through careful 
planning, recommendations may be formulated that 
give due consideration to individual civil rights, the 
patients' rights to confidentiality, and the rights of 
the public at large in the protection of public health. 
The Centers for Disease Control provided "Precau-
tions for Clinical and Laboratory Staffs" in November 
1982.41 Guidelines for children in public schools and 
day-care facilities were issued August 1985.42 These 
recommendations suggest exclusion of children with 
AIDS from day-care facilities. A confidential panel 
should be convened to make a decision regarding · 
school attendance. for each child with AIDS. These 
decisions should be based on the child's behavior, neu-
rologic development, and physical condition. In each 
case, risks and benefits to both the infected child and 
other school children or employees should be carefully 
considered. OJ 
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11---------AN ACT RELATING TO EDUCATION: MANDATING AIDS 
PREVENTION EDUCATION FOR STUDENTS; PROVIDING 
PROCEDURES AND REQUIREMENTS FOR SUCH EDUCATION; 
PROVIDING FOR CODIFICATION; PROVIDING AN OPERATIVE 
DATE; AND DECLARING AN EMERGENC~ ·----------------------------~1 
BE IT ENACTED BY THE PEOPLE OF THE STATE 9F OKLAHOMA: 
SECTION 1. NEW LAW A new section of law to be codified in 
the Oklahoma Statutes as Section 11-1~3.3 of Title 70, unless there 
is created a duplication in numbering, reads as follows: 
A. Acquired immune deficiency syndrome (AID§) prevention 
education shall be taught in the public schools of· this state. AIDS prevention education shall be limited to the discussion of the 
disease AIDS and its spread and prevention. Students shall receive 
such education: 
1. at the option of the local school district, a minimum of once 
during the period from grade five through grade six; 
2. a minimum of once during the period from grade seven through 
grade nine; and 
3. a mini~~m of once during the period from grade ten through 
grade twelve. 
B, The State Department of Education shall develop curriculum . 
and materials for AIDS prevention education in conjunction with the St"ate Department of Health. · A sctiool district may also develop its 
own AIDS prevention education curriculum and materials. Any 
curriculum and materials developed for use in the public schools 
shall be approved for medical accuracy by the State Department of 
Health. A school district may use any curriculum and materials which have been developed and approved pursuant to this subsection. 
C. School districts shall make the curriculum and materials that will be used to teach AIDS prevention education available for inspection by the parents and guardians of the students that will be involved with the curriculum and materials. Furthermore, the 
curriculum must be limited in time frame to deal only with factual medical information for AIDS prevention. The school districts, at least one (l) month prior to teaching AIDS prevention education in 
• 
any classroom, shall conduct for the parents and guardians of the 
students involved during weekend and evening hours at least one 
presentation concerning the curriculum and materials that will be 
used for such education. No student shall be required to participate 
in AIDS prevention education if a parent or guardian of the student 
objects in writing to such participation. 
D. AIDS prevention education shall specifically teach students 
that: 
1. engaging in homosexual activity, promiscuous sexual activity, 
intravenous drug use or contact with contaminated blood products is 
now known to be primarily responsible for contact with the AIDS 
virus; 
2. avoiding the activities specified in paragraph 1 of this 
subsection is the only method of preventing the spread of the virus; 
3. sexual intercourse, with or without condoms, with any person 
testing positive for human immunodeficiency virus (HIV) antibodies, 
or any other person infected with HIV, places that individual in a 
high risk category for developing AIDS. 
E. The program of AIDS prevention education shall teach that 
abstinence from sexual activity is the only certain means for the 
prevention of the spread or contraction of the AIDS virus through 
sexual contact. It shall also teach that artificial means of birth 
control are not a certain means of preventing the spread of the AIDS 
virus and reliance on such methods puts a person at risk for exposure 
to the disease. 
F. The State pepartment of Health and the State Department of 
Education shall update AIDS education curriculum material as newly 
discovered medical facts make it necessary. 
SECTION 2. This act shall become operative July 1, 1987. 
SEtTION 3. It being immediately, necessary for the preservation 
of ·the public peace, health and safety, an emergency is hereby 
declared to exist, by reason whereof this act shall take effect and 
be in full force from and after its passage and approval.--------------~1 
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